<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Isotretinoin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Isotretinoin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Isotretinoin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Isotretinoin</b>, also known as <b>13-<i>cis</i>-retinoic acid</b> and sold under the brand name <b>Accutane</b> among others, is a medication primarily used to treat severe acne. It is also used to prevent certain skin cancers (squamous-cell carcinoma), and in the treatment of other cancers. It is used to treat harlequin-type ichthyosis, a usually lethal skin disease, and lamellar ichthyosis. It is a retinoid, meaning it is related to <a href="Vitamin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_A" title="Vitamin A">vitamin A</a>, and is found in small quantities naturally in the body. Its isomer, <a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">tretinoin</a>, is also an acne drug.</p>


<div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">Tretinoin</a>.</div>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Isotretinoin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Isotretinoin_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Isotretinoin_structure.svg.png" data-file-width="512" data-file-height="179" data-file-type="drawing" height="87" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Isotretinoin3d.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Isotretinoin3d.svg.png" data-file-width="948" data-file-height="407" data-file-type="drawing" height="107" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><a href="Tretinoin.htm#Etymology" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin#Etymology" title="Tretinoin">See note at <i>tretinoin</i></a><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Accutane, Roaccutane, others<span class="mw-ref" id="cite_ref-brands_1-0"><a href="#cite_note-brands-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/isotretinoin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/isotretinoin.html'" tppabs="https://www.drugs.com/monograph/isotretinoin.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a681043.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a681043.html'" tppabs="https://medlineplus.gov/druginfo/meds/a681043.html" class="external text external">a681043</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Isotretinoin&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Isotretinoin&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Isotretinoin&SearchType=BasicSearch" class="external text external">Isotretinoin</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>X (High risk)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, topical</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>D10AD04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=D10AD04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=D10AD04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=D10AD04" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>Variable</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>99.9%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>10–20 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney and fecal</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(2<i>Z</i>,4<i>E</i>,6<i>E</i>,8<i>E</i>)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=4759-48-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=4759-48-2'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=4759-48-2" class="external text external">4759-48-2</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5282379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5282379'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5282379" class="external text external">5282379</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7600  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7600'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7600" class="external text external">7600</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00982  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00982'" tppabs="https://www.drugbank.ca/drugs/DB00982" class="external text external">DB00982</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4445539.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4445539.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4445539.html" class="external text external">4445539</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=EH28UP18IF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=EH28UP18IF'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=EH28UP18IF" class="external text external">EH28UP18IF</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00348  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00348'" tppabs="https://www.kegg.jp/entry/D00348" class="external text external">D00348</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6067  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6067'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6067" class="external text external">CHEBI:6067</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL547  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL547'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL547" class="external text external">ChEMBL547</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID4023177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID4023177'" tppabs="https://comptox.epa.gov/dashboard/DTXSID4023177" class="external text external">DTXSID4023177</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.022.996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.022.996'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.022.996" class="external text external">100.022.996</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>20</sub><span>H</span><sub>28</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">300.442</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29%5CC%3DC%28%2FC%3DC%2FC%3DC%28%2FC%3DC%2FC1%3DC%28%2FCCCC1%28C%29C%29C%29C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29%5CC%3DC%28%2FC%3DC%2FC%3DC%28%2FC%3DC%2FC1%3DC%28%2FCCCC1%28C%29C%29C%29C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29%5CC%3DC%28%2FC%3DC%2FC%3DC%28%2FC%3DC%2FC1%3DC%28%2FCCCC1%28C%29C%29C%29C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)\C=C(/C=C/C=C(/C=C/C1=C(/CCCC1(C)C)C)C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:SHGAZHPCJJPHSC-XFYACQKRSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477168707&page2=Isotretinoin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477168707&page2=Isotretinoin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477168707&page2=Isotretinoin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>The most common adverse effects are a transient worsening of acne (lasting 1–4 months), dry lips (cheilitis), dry and fragile skin, and an increased susceptibility to sunburn.  Uncommon and rare side effects include muscle aches and pains (myalgias), and headaches. Isotretinoin is known to cause birth defects due to in-utero exposure because of the molecule's close resemblance to <a href="Retinoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinoic_acid" title="Retinoic acid">retinoic acid</a>, a natural vitamin A derivative which controls normal embryonic development. It is also associated with psychiatric side effects, most commonly depression but also, more rarely, psychosis and unusual behaviours. Other rare side effects include hyperostosis, and premature epiphyseal closure, have been reported to be persistent.</p>

<p>In the United States, a special procedure is required to obtain the pharmaceutical. In most other countries, a consent form is required which explains these risks. In other countries, such as Israel, it is prescribed like any other medicine from a dermatologist (after proper blood tests). </p>

<p>Women taking isotretinoin must not get pregnant during and for one month after the discontinuation of isotretinoin therapy. Sexual abstinence or effective contraception is mandatory during this period. Barrier methods by themselves (e.g., condoms) are not considered adequate due to the unacceptable failure rates of approximately 3%. Women who become pregnant while taking isotretinoin therapy are generally counseled to have an abortion.</p>


<p>It was patented in 1969 and approved for medical use in 1982.<span class="mw-ref" id="cite_ref-Fis2006_2-0"><a href="#cite_note-Fis2006-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It sold well, but in 2009, Roche decided to discontinue manufacturing due to diminishing market share due to the availability of the many generic versions and the settling of multiple lawsuits over side effects. It continues to be manufactured as of 2019 by Absorica, Amnesteem, Claravis, Myorisan, Sotret, and Zenatane.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Isotretinoin is used primarily for severe cystic acne and acne that has not responded to other treatments.<span class="mw-ref" id="cite_ref-pmid19588674_4-0"><a href="#cite_note-pmid19588674-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-pmid20436884_5-0"><a href="#cite_note-pmid20436884-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-UKLabel2015_6-0"><a href="#cite_note-UKLabel2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-USlabel2010_7-0"><a href="#cite_note-USlabel2010-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span>  Many dermatologists also support its use for treatment of lesser degrees of acne that prove resistant to other treatments, or that produce physical or psychological scarring.<span class="mw-ref" id="cite_ref-pmid17276540_8-0"><a href="#cite_note-pmid17276540-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Isotretinoin is not indicated for treatment of prepubertal acne and is not recommended in children less than 12 years of age.<span class="mw-ref" id="cite_ref-:0_9-0"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>It is also somewhat effective for hidradenitis suppurativa and some cases of severe rosacea.<span class="mw-ref" id="cite_ref-Micromedex_10-0"><a href="#cite_note-Micromedex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It can also be used to help treat harlequin ichthyosis, lamellar ichthyosis and is used in xeroderma pigmentosum cases to relieve keratoses. Isotretinoin has been used to treat the extremely rare condition fibrodysplasia ossificans progressiva. It is also used for treatment of neuroblastoma, a form of nerve cancer.</p>

<p>Isotretinoin therapy has furthermore proven effective against genital warts in experimental use, but is rarely used for this indication as there are more effective treatments. Isotretinoin may represent an efficacious and safe alternative systemic form of therapy for <span class="new">recalcitrant condylomata acuminata</span> (RCA) of the cervix. In most countries this therapy is currently unapproved and only used if other therapies failed.<span class="mw-ref" id="cite_ref-Oral_isotretinoin_Therapy_11-0"><a href="#cite_note-Oral_isotretinoin_Therapy-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Unapproved_Isotretinoin_12-0"><a href="#cite_note-Unapproved_Isotretinoin-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Prescribing_restrictions">Prescribing restrictions</h3></summary>
    
<p>Isotretinoin is a teratogen; there is about a 20–35% risk for congenital defects in infants exposed to the drug <i>in utero</i>, and about 30–60% of children exposed to isotretinoin prenatally have been reported to show neurocognitive impairment.<span class="mw-ref" id="cite_ref-Choi2013_13-0"><a href="#cite_note-Choi2013-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span>  Because of this, there are strict controls on prescribing isotretinoin to women who may become pregnant and women who become pregnant while taking isotretinoin are strongly advised to terminate their pregnancies.<span class="mw-ref" id="cite_ref-Choi2013_13-1"><a href="#cite_note-Choi2013-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>In most countries, isotretinoin can only be prescribed by dermatologists or specialist physicians; some countries also allow limited prescription by general practitioners and family doctors. In the United Kingdom<span class="mw-ref" id="cite_ref-BNF47_14-0"><a href="#cite_note-BNF47-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> and Australia,<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> isotretinoin may be prescribed only by or under the supervision of a consultant dermatologist. Because severe cystic acne has the potential to cause permanent scarring over a short period, restrictions on its more immediate availability have proved contentious.<span class="mw-ref" id="cite_ref-James_1996_17-0"><a href="#cite_note-James_1996-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> In New Zealand, isotretinoin can be prescribed by any doctor but subsidised only when prescribed by a vocationally-registered general practitioner, dermatologist or nurse practitioner.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>In the United States, since March 2006 the dispensing of isotretinoin is run through a website called iPLEDGE.  The FDA required the companies marketing the drug in the US, which at the time that iPLEDGE was launched were Roche, Mylan, Barr, and Ranbaxy, to put this website in place as a risk evaluation and mitigation strategy. These companies formed a group called the Isotretinoin Products Manufacturing Group, and it hired Covance to run the website.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span>  Prescribers, pharmacists, and all people to whom the drug is prescribed need to register on the site and log information into it.  Women with child-bearing potential must commit to using two forms of effective contraception simultaneously for the duration of isotretinoin therapy and for a month immediately preceding and a month immediately following therapy. Additionally they must have two negative pregnancy tests 30 days apart and have negative pregnancy tests before each prescription is written.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Increasingly higher dosages will result in higher toxicity, resembling vitamin A toxicity. Adverse effects include:<span class="mw-ref" id="cite_ref-UKlabel_23-0"><a href="#cite_note-UKlabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<table class="wikitable">
<tbody><tr><th>
<p>Type of disorders</p></th>
<th>
<p>Very common  (≥ 1/10) </p></th>
<th>
<p>Common (≥ 1/100, &lt; 1/10) </p></th>
<th>
<p>Rare (≥ 1/10 000,&lt; 1/1000) </p></th>
<th>
<p>Very rare (≤ 1/10 000)</p></th>
<th>Unknown Frequency</th></tr>
<tr>
<td><b>Infections</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Gram positive (mucocutaneous)</li></ul>
<p>bacterial infection</p></td>
<td></td></tr>
<tr>
<td><b>Blood and lymphatic system</b></td>
<td>
<ul><li>Anemia</li>
<li>Increased red blood cell sedimentation rate</li>
<li>Thrombocytopenia</li>
<li>Thrombocytosis</li></ul></td>
<td>
<ul><li>Neutropenia</li></ul></td>
<td></td>
<td>
<ul><li>Lymphadenopathy</li></ul></td>
<td></td></tr>
<tr>
<td><b>Immune system</b></td>
<td></td>
<td></td>
<td>
<ul><li>Allergic skin reaction</li>
<li>Anaphylactic reactions</li>
<li>Hypersensitivity</li></ul></td>
<td></td>
<td></td></tr>
<tr>
<td><b>Metabolism</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Diabetes mellitus</li>
<li>Hyperuricaemia</li></ul></td>
<td></td></tr>
<tr>
<td><b>Psychiatric</b></td>
<td></td>
<td></td>
<td>
<ul><li>Depression</li>
<li>Aggravated depression</li>
<li>Aggressive tendencies</li>
<li>Anxiety</li>
<li>Mood alterations</li></ul></td>
<td>
<ul><li>Abnormal behaviour</li>
<li>Psychotic disorder</li>
<li>Suicidal ideation</li>
<li>Suicide attempt</li>
<li>Suicide</li></ul></td>
<td></td></tr>
<tr>
<td><b>Nervous system</b></td>
<td></td>
<td>
<ul><li>Headache</li></ul></td>
<td></td>
<td>
<ul><li>Idiopathic intracranial hypertension</li>
<li>Convulsions</li>
<li>Drowsiness</li>
<li>Dizziness</li></ul></td>
<td></td></tr>
<tr>
<td><b>Eye</b></td>
<td>
<ul><li>Blepharitis</li>
<li>Conjunctivitis</li>
<li>Dry eyes</li>
<li>Eye irritation</li></ul></td>
<td></td>
<td></td>
<td>
<ul><li>Blurred vision</li>
<li>Cataract</li>
<li>Colour blindness</li>
<li>Contact lens intolerance</li>
<li>Corneal opacity</li>
<li>Decreased night vision</li>
<li>Keratitis</li>
<li>Papilloedema</li>
<li>Photophobia</li>
<li>Visual disturbances</li></ul></td>
<td></td></tr>
<tr>
<td><b>Ear</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Impaired hearing</li></ul></td>
<td></td></tr>
<tr>
<td><b>Vascular</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Vasculitis (i.e. Granulomatosis with polyangiitis, allergic vasculitis)</li></ul></td>
<td></td></tr>
<tr>
<td><b>Respiratory, thoracic</b> <br>
<p><b>and mediastinal</b></p></td>
<td></td>
<td>
<ul><li>Epistaxis</li>
<li>Nasal dryness</li>
<li>Nasopharyngitis</li></ul></td>
<td></td>
<td>
<ul><li>Bronchospasm (particularly in people with asthma)</li>
<li>Hoarseness</li></ul></td>
<td></td></tr>
<tr>
<td><b>Gastrointestinal</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Colitis</li>
<li>Ileitis</li>
<li>Dry throat</li>
<li>Gastrointestinal haemorrhage</li>
<li>Haemorrhagic diarrhoea</li>
<li>Inflammatory bowel disease</li>
<li>Nausea</li>
<li>Pancreatitis</li></ul></td>
<td></td></tr>
<tr>
<td><b>Hepatobiliary</b></td>
<td>
<ul><li>Increased transaminase</li></ul></td>
<td></td>
<td></td>
<td>
<ul><li>Hepatitis</li></ul></td>
<td></td></tr>
<tr>
<td><b>Skin and</b><br> 
<p><b>subcutaneous tissues</b></p></td>
<td>
<ul><li>Cheilitis</li>
<li>Dermatitis</li>
<li>Dry skin</li>
<li>Localised exfoliation</li>
<li>Pruritus</li>
<li>Rash erythematous</li>
<li>Skin fragility (with a risk of frictional trauma)</li></ul></td>
<td></td>
<td>
<ul><li>Alopecia- hair shedding from telogen effluvium</li></ul></td>
<td>
<ul><li>Acne fulminans</li>
<li>Aggravated acne (acne flare)</li>
<li>Erythema (facial)</li>
<li>Exanthema</li>
<li>Hair disorders</li>
<li>Hirsutism</li>
<li>Nail dystrophy</li>
<li>Paronychia</li>
<li>Photosensitivity reaction</li>
<li>Pyogenic granuloma</li>
<li>Skin hyperpigmentation</li>
<li>Increased sweating</li></ul></td>
<td>
<ul><li>Erythema multiforme</li>
<li>Stevens-Johnson Syndrome</li>
<li>Toxic epidermal necrolysis.</li></ul></td></tr>
<tr>
<td><b>Musculo-skeletal and</b><br> 
<p><b>connective tissue</b></p></td>
<td>
<ul><li>Arthralgia</li>
<li>Myalgia</li>
<li>Back pain</li></ul></td>
<td></td>
<td></td>
<td>
<ul><li>Arthritis</li>
<li>Calcinosis (calcification of ligaments</li></ul>
<p>and tendons)</p>
<ul><li>Premature epiphyseal fusion</li>
<li>Exostosis</li>
<li>Hyperostosis</li>
<li>Osteopenia</li>
<li>Tendonitis</li></ul></td>
<td>
<ul><li>Rhabdomyolysis</li></ul></td></tr>
<tr>
<td><b>Kidney and urinary</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Glomerulonephritis</li></ul></td>
<td>
<ul><li>Dark or cola-coloured urine<span class="mw-ref" id="cite_ref-:0_9-1"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></li></ul></td></tr>
<tr>
<td><b>Reproductive system and breast disorders</b></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Sexual dysfunction, including erectile dysfunction and decreased libido</li></ul></td></tr>
<tr>
<td><b>General</b></td>
<td></td>
<td></td>
<td></td>
<td>
<ul><li>Increased formation of granulation tissue</li>
<li>Malaise</li></ul></td>
<td></td></tr>
<tr>
<td><b>Investigation</b></td>
<td>
<ul><li>Increased triglycerides</li>
<li>Decreased HDL</li></ul></td>
<td>
<ul><li>Increased blood cholesterol</li>
<li>Increased blood glucose</li>
<li>Haematuria</li>
<li>Proteinuria</li></ul></td>
<td></td>
<td>
<ul><li>Increased creatine phosphokinase</li></ul></td>
<td></td></tr>
<tr class="mw-empty-elt"></tr>
</tbody></table>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Possible_permanent_effects">Possible permanent effects</h3></summary>
    
<p>Isotretinoin may stop long bone growth in young people who are still growing.<span class="mw-ref" id="cite_ref-USlabel2010_7-1"><a href="#cite_note-USlabel2010-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Premature epiphyseal closure can occur in people with acne receiving recommended doses<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> of Accutane.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Generally though, premature epiphyseal closure seems to be primarily related to:</p>

<ul><li>high doses of isotretinoin beyond the recommended dose of 1mg/kg/day</li></ul>

<ul><li>long duration beyond the usual course of what is required for an acne patient for treatment (usually 5-7 months)</li></ul>

<ul><li>early onset of treatment (young teenage age 12-14 or younger)<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></li></ul>

<p>Isotretinoin is known to cause meibomian gland dysfunction which causes persistent keratoconjunctivitis sicca (dry eye).<span class="mw-ref" id="cite_ref-Moy2015rev_29-0"><a href="#cite_note-Moy2015rev-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span>  Problems with the meibomian and salivary glands are likely due to the non-selective apoptosis of the cells of the exocrine glands.<span class="mw-ref" id="cite_ref-Lambert_1989_30-0"><a href="#cite_note-Lambert_1989-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Decreased night vision has been reported to persist in some people after discontinuation of isotretinoin therapy.<span class="mw-ref" id="cite_ref-autogenerated299_31-0"><a href="#cite_note-autogenerated299-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Skin">Skin</h3></summary>
    
<p>The most common side effects are mucocutaneous: dry lips, skin and nose. Other common mucocutaneous side effects are inflammation and chapping of the lips (cheilitis), redness of the skin (erythema), rashes, peeling, eczema (dermatitis), itching (pruritus) and nose bleeds (epistaxis).<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-0"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Absence of dryness of the lips is considered an indication of non-compliance with treatment (not taking the drug as advised), as it occurs in almost all people who take it.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-1"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<p>Regular use of lip balm and moisturizer is recommended throughout a course of treatment to reduce these problems. The dose may need to be decreased to reduce the severity of these side effects.<span class="mw-ref" id="cite_ref-pmid16703787_33-0"><a href="#cite_note-pmid16703787-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span>  The skin becomes more fragile—especially to frictional forces—and may not heal as quickly as normal. Wound healing is delayed. For this reason elective surgery, waxing of hair, tattooing, tattoo removal, piercings, dermabrasion, exfoliation, etc., are not recommended. Treatment of acne scars is generally deferred until 12 months after completion of a course of isotretinoin.</p>

<p>Acne usually flares up 2–3 weeks into the treatment and is usually mild and tolerable. Occasionally this flare-up is severe, necessitating oral antiobiotics such as <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a>. A short course of oral <a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">prednisolone</a> may be required. Some dermatologists favour a few weeks of pre-treatment with oral antibiotics before commencing isotretinoin to reduce the chance of a severe flare. A "stepped" course may also be used to reduce the chance of this initial flare, by which the initial dose is low (e.g. 0.5<span>&nbsp;</span>mg/kg) and subsequently increased throughout the course.</p>

<p>Isotretinoin use can rarely lead to a more severe form of acne, acne fulminans.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Teratogenicity">Teratogenicity</h3></summary>
    
<p> 
Isotretinoin is a teratogen highly likely to cause birth defects if taken by women during pregnancy or even a short time before conception. A few of the more common birth defects this drug can cause are hearing and visual impairment, missing or malformed earlobes, facial dysmorphism, and abnormalities in brain function. Isotretinoin is classified as FDA Pregnancy Category X and ADEC Category X, and use is contraindicated in pregnancy.<span class="mw-ref" id="cite_ref-Micromedex_10-1"><a href="#cite_note-Micromedex-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In the EU, isotretinoin (oral) is contraindicated in pregnancy and must not be taken by women able to have children unless the conditions of a pregnancy prevention programme are met.<span class="mw-ref" id="cite_ref-:2_34-0"><a href="#cite_note-:2-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>

<p>The manufacturer recommends pregnancy be ruled out two weeks prior to commencement of isotretinoin, and women should use two simultaneous forms of effective contraception at least one month prior to commencement, during, and for at least one month following isotretinoin therapy.<span class="mw-ref" id="cite_ref-RoaccutanePI_35-0"><a href="#cite_note-RoaccutanePI-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<p>In the U.S., around 2000 women became pregnant while taking the drug between 1982 and 2000, with most pregnancies ending in abortion or miscarriage. About 160 babies with birth defects were born.  After the FDA put the more strict iPLEDGE program in place for the companies marketing the drug in the US, in 2011, 155 pregnancies occurred among 129,544 women of childbearing potential taking isotrentinoin (0.12%).<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>

<p>People taking isotretinoin are not permitted to donate blood during and for at least one month after discontinuation of therapy due to its teratogenicity.<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Psychological_effects">Psychological effects</h3></summary>
    
<p>Rare psychological side effects may include depression, worsening of pre-existing depression, aggressive tendencies, irritable mood and anxiety. Very rare effects include abnormal behaviour, psychosis, suicidal ideation, suicide attempts and suicide.<span class="mw-ref" id="cite_ref-UKLabel2015_6-1"><a href="#cite_note-UKLabel2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Bremner2012rev_38-0"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-Kontaxakis2009rev_39-0"><a href="#cite_note-Kontaxakis2009rev-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-Borovaya2013rev_40-0"><a href="#cite_note-Borovaya2013rev-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span>  In a total of 5577 adverse reactions reported to the UK's MHRA up to 31 March 2017, the plurality (1207, or 22%) concerned psychiatric effects.<span class="mw-ref" id="cite_ref-MHRAreport_41-0"><a href="#cite_note-MHRAreport-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> There were 85 reports of suicidal ideation, 56 of completed suicide and 43 of suicide attempts.<span class="mw-ref" id="cite_ref-MHRAreport_41-1"><a href="#cite_note-MHRAreport-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>The association between isotretinoin use and psychopathology has been controversial. Beginning in 1983, isolated case reports emerged suggesting mood change, particularly depression, occurring during or soon after isotretinoin use.<span class="mw-ref" id="cite_ref-bjd2010_42-0"><a href="#cite_note-bjd2010-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> A number of studies have been conducted since then of the drug's effect on depression, psychosis, suicidal thoughts and other psychological effects.<span class="mw-ref" id="cite_ref-bjd2010_42-1"><a href="#cite_note-bjd2010-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Depression_and_suicidality">Depression and suicidality</h4></summary>
    
<p>Isotretinoin is the only non-psychiatric drug on the FDA's top 10 list of drugs associated with depression<span class="mw-ref" id="cite_ref-Kontaxakis2009rev_39-1"><a href="#cite_note-Kontaxakis2009rev-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-:1_43-0"><a href="#cite_note-:1-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> and is also within the top 10 for suicide attempts.<span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> A black box warning for suicide, depression and psychosis has been present on isotretinoin's packaging in the United States since 2005.<span class="mw-ref" id="cite_ref-:1_43-1"><a href="#cite_note-:1-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> In March 2018, European Medicines Agency issued a warning on a possible risk of neuropsychiatric disorders (such as depression, anxiety and mood changes) following the use of oral retinoids, including isotretinoin. <span class="mw-ref" id="cite_ref-:2_34-1"><a href="#cite_note-:2-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>

<p>In 2012, a systematic review covering all articles in the literature related to isotretinoin, depression and suicide, as well as articles related to class effect, dose response, and biologic plausibility found that the literature reviewed was consistent with an association of isotretinoin administration and depression and with suicide in a subgroup of vulnerable individuals.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-1"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Following this systematic review, in a 2014 review a group of Australian dermatologists and psychiatrists collaborated on a set of recommendations for safe prescribing of isotretinoin.<span class="mw-ref" id="cite_ref-Rowe2014_45-0"><a href="#cite_note-Rowe2014-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> However, whether isotretinoin use is causally associated with mental illness remains controversial.<span class="mw-ref" id="cite_ref-Rowe2014_45-1"><a href="#cite_note-Rowe2014-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>

<p>Evidence for depression being causally associated with isotretinoin use includes 41 reports of positive challenge/dechallenge/rechallenge with isotretinoin, involving administering isotretinoin, withdrawing the drug and then re-administering it.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-2"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> The majority of these cases had no psychiatric history.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-3"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> There is also a temporal relationship between development of depression and initiation of isotretinoin treatment, with most cases developing after 1–2 months of treatment.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-4"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Further, higher doses of isotretinoin increases the risk of developing depression, with 25% of people showing depression on a dose of 3<span>&nbsp;</span>mg/kg/day as compared with 3–4% at normal doses.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-5"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Studies have uncovered <a href="#CNS_activities" title="Isotretinoin">several biological processes</a> which may credibly explain the affective changes induced by isotretinoin.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Psychosis">Psychosis</h4></summary>
    
<p>Isotretinoin has also been linked to psychosis.<span class="mw-ref" id="cite_ref-UKlabel_23-1"><a href="#cite_note-UKlabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Many of the side effects of isotretinoin mimic hypervitaminosis A, which has been associated with psychotic symptoms.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-6"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> The dopamine hypothesis of schizophrenia and psychosis suggests that an increase in dopaminergic stimulation or sensitivity in the limbic system causes psychotic symptoms.<span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>

<p>It has been suggested that dysregulation of retinoid receptors by retinoids such as isotretinoin may cause schizophrenia.<span class="mw-ref" id="cite_ref-:3_47-0"><a href="#cite_note-:3-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> The evidence for this is threefold: transcriptional activation of the dopamine D2 receptor – in addition to serotonin and glutamate receptors – is regulated by <a href="Retinoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinoic_acid" title="Retinoic acid">retinoic acid</a>;<span class="mw-ref" id="cite_ref-:3_47-1"><a href="#cite_note-:3-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> schizophrenia and the retinoid cascade have been linked to the same gene loci;<span class="mw-ref" id="cite_ref-:3_47-2"><a href="#cite_note-:3-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> and retinoid dysfunction causes congenital anomalies identical to those observed in people with schizophrenia.<span class="mw-ref" id="cite_ref-:3_47-3"><a href="#cite_note-:3-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> Further, the expression of dopamine receptors has indeed been shown to be regulated by retinoic acid.<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Musculoskeletal">Musculoskeletal</h3></summary>
    
<p>Isotretinoin has a number of muscoloskeletal effects. Myalgia (muscular pain) and arthralgia (joint pain) are rare side effects.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-2"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Retinoids, such as high dose etretinate, are well known to cause bone changes, the most common type of which is hyperostotic changes (excessive bone growth), especially in growing children and adolescents.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-3"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Other problems include premature epiphyseal closure and calcification of tendons and ligaments.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-4"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> The bones of the spine and feet are most commonly affected. Risk factors for skeletal effects include older age, greater dosage and longer course of treatment. Most bone changes cause no symptoms and may only be noticed using X-ray imaging.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-5"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Gastrointestinal">Gastrointestinal</h3></summary>
    
<p>Isotretinoin may cause non-specific gastrointestinal symptoms including nausea, diarrhea and abdominal pain.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-6"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> The drug is associated with inflammatory bowel disease (IBD)—ulcerative colitis, but not Crohn's disease.<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span>  There are also reports of people developing irritable bowel syndrome (IBS) and worsening of existing IBS.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Eyes">Eyes</h3></summary>
    
<p>Isotretinoin and other retinoids are well known to affect the eyes. Dry eyes are very common during treatment and is caused by isotretinoin's apoptotic effect on the meibomian glands. Some people develop contact lens intolerance as a result.<span class="mw-ref" id="cite_ref-Brelsford2008rev_32-7"><a href="#cite_note-Brelsford2008rev-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> In some people, these changes are long-lasting or irreversible and represent Meibomian Gland Dysfunction (MGD).<span class="mw-ref" id="cite_ref-Moy2015rev_29-1"><a href="#cite_note-Moy2015rev-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Other common effects on the eyes include inflammation of the eyelid (blepharitis), red eye caused by conjunctivitis and irritation of the eye. More rare ocular side effects include blurred vision, decreased night vision (which may be permanent), colour blindness, development of corneal opacities, inflammation of the cornea (keratitis), swelling of the optic disk (papilloedema, associated with IIH), photophobia and other visual disturbances.<span class="mw-ref" id="cite_ref-UKLabel2015_6-2"><a href="#cite_note-UKLabel2015-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Sexual">Sexual</h3></summary>
    
<p>Isotretinoin is also associated with sexual side effects, namely erectile dysfunction and reduced libido.<span class="mw-ref" id="cite_ref-UKlabel_23-2"><a href="#cite_note-UKlabel-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> In October 2017, the UK MHRA issued a Drug Safety Update to physicians in response to reports of these problems.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> This was in response to an EU review, published in August 2017, which states that a plausible physiological explanation of these side effects "may be a reduction in plasma testosterone".<span class="mw-ref" id="cite_ref-:0_9-2"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> The review also stated that "the product information should be updated to include ‘sexual dysfunction including erectile dysfunction and decreased libido’ as an undesirable effect with an unknown frequency".<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> There have also been reports of spermatogenesis disorders, such as oligospermia. 27 cases of sexual dysfunction report either negative dechallenge or positive dechallenge.<span class="mw-ref" id="cite_ref-:0_9-3"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>Isotretinoin's exact mechanism of action is unknown, but several studies have shown that isotretinoin induces apoptosis (programmatic cell death) in various cells in the body. Cell death may be instigated in the meibomian glands,<span class="mw-ref" id="cite_ref-Lambert_1989_30-1"><a href="#cite_note-Lambert_1989-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-Kremer1994_55-0"><a href="#cite_note-Kremer1994-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> hypothalamic cells,<span class="mw-ref" id="cite_ref-Griffin_2010_56-0"><a href="#cite_note-Griffin_2010-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> hippocampus cells<span class="mw-ref" id="cite_ref-Crandall2004_57-0"><a href="#cite_note-Crandall2004-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-Sakai_2004_58-0"><a href="#cite_note-Sakai_2004-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> and—important for treatment of acne—in sebaceous gland cells.<span class="mw-ref" id="cite_ref-Nelson2011_59-0"><a href="#cite_note-Nelson2011-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-Nelson_2006_60-0"><a href="#cite_note-Nelson_2006-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> Isotretinoin has a low affinity for retinoic acid receptors (RAR) and retinoid X receptors (RXR), but may be converted intracellularly to metabolites that act as agonists of RAR and RXR nuclear receptors.<span class="mw-ref" id="cite_ref-pmid20436884_5-1"><a href="#cite_note-pmid20436884-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>One study suggests the drug amplifies production of neutrophil gelatinase-associated lipocalin (NGAL) in the skin, which has been shown to reduce sebum production by inducing apoptosis in sebaceous gland cells, while exhibiting an antimicrobial effect on Cutibacterium acnes.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-pmid18317594_63-0"><a href="#cite_note-pmid18317594-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> The drug decreases the size and sebum output of the sebaceous glands.<span class="mw-ref" id="cite_ref-Peck_64-0"><a href="#cite_note-Peck-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Isotretinoin is the only available acne drug that affects all four major pathogenic processes in acne, which distinguishes it from alternative treatments (such as antibiotics) and accounts for its efficacy in severe, nodulocystic cases.<span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> The effect of Isotretinoin on sebum production can be temporary,<span class="mw-ref" id="cite_ref-USlabel2010_7-2"><a href="#cite_note-USlabel2010-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> or remission of the disease can be "complete and prolonged."<span class="mw-ref" id="cite_ref-Peck_64-1"><a href="#cite_note-Peck-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-Farrell_66-0"><a href="#cite_note-Farrell-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-Jones_67-0"><a href="#cite_note-Jones-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span></p>

<p>Isotretinoin has been speculated to down-regulate the enzyme telomerase and hTERT, inhibiting "cellular immortalization and tumorigenesis."<span class="mw-ref" id="cite_ref-Pendino_68-0"><a href="#cite_note-Pendino-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> In a 2007 study, Isotretinoin was proven to inhibit the action of the metalloprotease MMP-9 (gelatinase) in sebum without any influence in the action of TIMP1 and TIMP2 (the tissue inhibitors of metalloproteases).<span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> It is already known that metalloproteases play an important role in the pathogenesis of acne.<span class="mw-ref" id="cite_ref-pmid12102663_70-0"><a href="#cite_note-pmid12102663-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="CNS_activities">CNS activities</h4></summary>
    
<p>A possible biological basis for the case reports of depression involves decreased metabolism in the orbitofrontal cortex (OFC) of the frontal lobe.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-7"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> It has also been found that decreased OFC metabolism was correlated with headaches.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-8"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> People reporting headache as a side effect often report comorbid neuropsychiatric symptoms, especially depression; a statistically significant relationship between headache and depression has been established.<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> It is suggested that people sensitive to isotretinoin-induced CNS effects may also be susceptible to other psychiatric side effects such as depression.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-9"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>Studies in mice and rats have found that retinoids, including isotretinoin, bind to dopaminergic receptors in the central nervous system.<span class="mw-ref" id="cite_ref-Kontaxakis2009rev_39-2"><a href="#cite_note-Kontaxakis2009rev-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span><span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> Isotretinoin may affect dopaminergic neurotransmission by disrupting the structure of dopamine receptors and decreasing dopaminergic activity.<span class="mw-ref" id="cite_ref-Borovaya2013rev_40-1"><a href="#cite_note-Borovaya2013rev-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> The dopaminergic system is implicated in numerous psychological disorders, including depression. Isotretinoin is also thought to affect the <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonergic</a> system – it increases expression of 5-HT<sub>1A</sub><span>&nbsp;</span>receptors in the pre-synaptic neuron, which inhibit serotonin secretion.<span class="mw-ref" id="cite_ref-Borovaya2013rev_40-2"><a href="#cite_note-Borovaya2013rev-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> Isotretinoin also directly and indirectly increases the translation of the serotonin transporter protein (SERT), leading to increased reuptake and consequently reduced synaptic availability of serotonin.<span class="mw-ref" id="cite_ref-Borovaya2013rev_40-3"><a href="#cite_note-Borovaya2013rev-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>

<p>Inhibition of hippocampal neurogenesis may also play a role in the development of isotretinoin-induced depression.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-10"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> A further effect of isotretinoin on the brain involves retinoic acid function in the hypothalamus, the hormone regulatory centre of the brain and part of the hypothalamus-pituitary-adrenal axis, a key part of the body's stress response.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-11"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Other brain regions regulated by <a href="Retinoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinoic_acid" title="Retinoic acid">retinoic acid</a> and potentially disrupted by isotretinoin include the frontal cortex and the striatum.<span class="mw-ref" id="cite_ref-Bremner2012rev_38-12"><a href="#cite_note-Bremner2012rev-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics_and_pharmacodynamics">Pharmacokinetics and pharmacodynamics</h3></summary>
    
<p>Oral Isotretinoin is best absorbed when taken with a high-fat meal, because it has a high level of lipophilicity.<span class="mw-ref" id="cite_ref-drugs.com_74-0"><a href="#cite_note-drugs.com-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> The efficacy of isotretinoin doubles when taken after a high-fat meal compared to when taken without food.<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> Due to Isotretinoin's molecular relationship to Vitamin A, it should not be taken with Vitamin A supplements due to the danger of toxicity through cumulative overdosing.<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> Accutane also negatively interacts with tetracycline, another class of acne drug, and with micro-dosed ('mini-pill') <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a> preparations, <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a>/ethinylestradiol ('OrthoNovum 7/7/7'), St. John's Wort, <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">phenytoin</a>, and systemic corticosteroids.</p>

<p>Isotretinoin is primarily (99.9%) bound to plasma proteins, mostly albumin. Three metabolites of Isotretinoin are detectable in human plasma after oral administration: 4-<i>oxo</i>-isotretinoin, retinoid acid (tretinoin), and 4-<i>oxo</i>-retinoic acid (4-<i>oxo</i>-tretinoin). Isotretinoin also oxidizes, irreversibly, to 4-<i>oxo</i>-isotretinoin—which forms its geometric isomer 4-<i>oxo</i>-tretinoin. After an orally-administered, 80<span>&nbsp;</span>mg dose of liquid suspension <sup>14</sup>C-isotretinoin, <sup>14</sup>C-activity in blood declines with a half-life of 90 hours.<span class="mw-ref" id="cite_ref-drugs.com_74-1"><a href="#cite_note-drugs.com-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> The metabolites of isotretinoin and its conjugates are then excreted in the subject's urine and faeces in relatively equal amounts.<span class="mw-ref" id="cite_ref-drugs.com_74-2"><a href="#cite_note-drugs.com-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> After a single, 80<span>&nbsp;</span>mg oral dose of Isotretinoin to 74 healthy adult subjects under fed conditions, the mean ±SD elimination half-life (t<sub>1/2</sub>) of isotretinoin and 4-<i>oxo</i>-isotretinoin were 21.0 ± 8.2 hours and 24.0 ± 5.3 hours, respectively.<span class="mw-ref" id="cite_ref-drugs.com_74-3"><a href="#cite_note-drugs.com-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> After both single and multiple doses, the observed accumulation ratios of isotretinoin ranged from 0.90 to 5.43 in people with cystic acne.<span class="mw-ref" id="cite_ref-drugs.com_74-4"><a href="#cite_note-drugs.com-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>The compound 13-cis retinoic acid was first studied in the 1960s at Roche Laboratories in Switzerland by Werner Bollag as a treatment for skin cancer. Experiments completed in 1971 showed that the compound was likely to be ineffective for cancer and, surprisingly, that it could be useful to treat acne. However, they also showed that the compound was likely to cause birth defects, so in light of the events around <a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">thalidomide</a>, Roche abandoned the product. In 1975, Gary Peck and Frank Yoder independently rediscovered the drug's use as a treatment of cystic acne while studying it as a treatment for lamellar ichthyosis, and published that work. Roche resumed work on the drug. In clinical trials, subjects were carefully screened to avoid including women who were or might become pregnant. Roche's New Drug Application for isotretinoin for the treatment of acne included data showing that the drug caused birth defects in rabbits. The FDA approved the application in 1982.</p>

<p>Scientists involved in the clinical trials published articles warning of birth defects at the same time the drug was launched in the US, but nonetheless isotretinoin was taken up quickly and widely, both among dermatologists and general practitioners. Cases of birth defects showed up in the first year, leading the FDA to begin publishing case reports and to Roche sending warning letters to doctors and placing warning stickers on drug bottles, and including stronger warnings on the label. Lawsuits against Roche started to be filed. In 1983 the FDA's advisory committee was convened and recommended stronger measures, which the FDA took and were that time unprecedented: warning blood banks not to accept blood from people taking the drug, and adding a warning to the label advising women to start taking contraceptives a month before starting the drug. However use of the drug continued to grow, as did the number of babies born with birth defects. In 1985 the label was updated to include a boxed warning. In early 1988 the FDA called for another advisory committee, and FDA employees prepared an internal memo estimating that around 1,000 babies had been born with birth defects due to isotretinoin, that up to around 1,000 miscarriages had been caused, and that between 5,000 and 7,000 women had had abortions due to isotretinoin. The memo was leaked to the New York Times<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> a few days before the meeting, leading to a storm of media attention. In the committee meeting, dermatologists and Roche each argued to keep the drug on the market but to increase education efforts; pediatricians and the CDC argued to withdraw the drug from the market. The committee recommended to restrict physicians who could prescribe the drug and to require a second opinion before it could be prescribed. The FDA, believing it did not have authority under the law to restrict who had the right to prescribe the drug, kept the drug on the market but took further unprecedented measures: it required to Roche to make warnings yet more visible and graphic, provide doctors with informed consent forms to be used when prescribing the drug, and to conduct follow up studies to test whether the measures were reducing exposure of pregnant women to the drug. Roche implemented those measures, and offered to pay for contraception counseling and pregnancy testing for women prescribed the drug; the program was called the "Pregnancy Prevention Program".</p>

<p>A CDC report published in 2000<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> showed problems with the Pregnancy Prevention Program and showed that the increase in prescriptions was from off-label use, and prompted Roche to revamp its program, renaming it the "Targeted Pregnancy Prevention Program" and adding label changes like requirements for two pregnancy tests, two kinds of contraception, and for doctors to provide pharmacists with prescriptions directly; providing additional educational materials, and providing free pregnancy tests. The FDA had another advisory meeting in late 2000 that again debated how to prevent pregnant women from being exposed to the drug; dermatologists testified about the remarkable efficacy of the drug, the psychological impact of acne, and demanded autonomy to prescribe the drug; others argued that the drug be withdrawn or much stricter measures be taken. In 2001 the FDA announced a new regulatory scheme called SMART (the System to Manage Accutane Related Teratogenicity) that required Roche to provide defined training materials to doctors, and for doctors to sign and return a letter to Roche acknowledging that they had reviewed the training materials, for Roche to then send stickers to doctors, which doctors would have to place on prescriptions they give people after they have confirmed a negative pregnancy test; prescriptions could only be written for 30 days and could not be renewed, thus requiring a new pregnancy test for each prescription.</p>

<p>In February 2002, Roche's patents for isotretinoin expired, and there are now many other companies selling cheaper generic versions of the drug. On June 29, 2009, Roche Pharmaceuticals, the original creator and distributor of isotretinoin, officially discontinued both the manufacture and distribution of their <b>Accutane</b> brand in the United States due to what the company described as business reasons related to low market share (below 5%), coupled with the high cost of defending personal-injury lawsuits brought by some people who took the drug.<span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> Generic isotretinoin will remain available in the United States through various manufacturers. Roche USA continues to defend Accutane and claims to have treated over 13 million people since its introduction in 1982. F. Hoffmann-La Roche Ltd. apparently will continue to manufacture and distribute <b>Roaccutane</b> outside of the United States.<span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span></p>

<p>Among others, actor James Marshall sued Roche over allegedly Accutane-related disease that resulted in removal of his colon.<span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span> The jury, however, decided that James Marshall had a pre-existing bowel disease.<span class="mw-ref" id="cite_ref-urlIts_Curtains_On_Actors_Accutane_Lawsuit_|_Pharmalot_82-0"><a href="#cite_note-urlIts_Curtains_On_Actors_Accutane_Lawsuit_|_Pharmalot-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></p>

<p>Several trials over inflammatory bowel disease claims have been held in the United States thus far, with many of them resulting in multimillion-dollar judgments against the makers of isotretinoin.<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brands">Brands</h3></summary>
    
<p>As of 2017 isotretinoin was marketed under many brand names worldwide: A-Cnotren, Absorica, Accuran, Accutane, Accutin, Acne Free, Acnecutan, Acnegen, Acnemin, Acneone, Acneral, Acnestar, Acnetane, Acnetin A, Acnetrait, Acnetrex, Acnogen, Acnotin, Acnotren, Acretin, Actaven, Acugen, Acutret, Acutrex, Ai Si Jie, Aisoskin, Aknal, Aknefug Iso, Aknenormin, Aknesil, Aknetrent, Amnesteem, Atlacne, Atretin, Axotret, Casius, Ciscutan, Claravis, Contracné, Curacne, Curacné, Curakne, Curatane, Cuticilin, Decutan, Dercutane, Effederm, Epuris, Eudyna, Farmacne, Flexresan, Flitrion, I-Ret, Inerta, Inflader, Inotrin, Isac, Isdiben, Isoacne, Isobest, Isocural, Isoderm, Isoface, IsoGalen, Isogeril, Isolve, Isoprotil, Isoriac, Isosupra, Isosupra Lidose, Isotane, Isotina, Isotinon, Isotren, Isotret, Isotretinoin, Isotretinoina, Isotretinoína, Isotretinoine, Isotretinoïne, Isotrétinoïne, Isotretinoinum, Isotrex, Isotrin, Isotroin, Izotek, Izotziaja, Lisacne, Locatret, Mayesta, Myorisan, Neotrex, Netlook, Nimegen, Noitron, Noroseptan, Novacne, Oralne, Oraret, Oratane, Piplex, Policano, Procuta, Reducar, Retin A, Roaccutan, Roaccutane, Roacnetan, Roacta, Roacutan, Rocne, Rocta, Sotret, Stiefotrex, Tai Er Si, Teweisi, Tretin, Tretinac, Tretinex, Tretiva, Tufacne, Zenatane, Zerocutan, Zonatian ME, and Zoretanin.<span class="mw-ref" id="cite_ref-brands_1-1"><a href="#cite_note-brands-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>As of 2017 it was marketed as a topical combination drug with <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a> under the brand names Isotrex Eritromicina, Isotrexin, and Munderm.<span class="mw-ref" id="cite_ref-brands_1-2"><a href="#cite_note-brands-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>While excessive bone growth has been raised a possible side effect, a 2006 review found little evidence for this.<span class="mw-ref" id="cite_ref-84"><a href="#cite_note-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Retinoid</li>
<li><a href="Etretinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etretinate" title="Etretinate">Etretinate</a></li>
<li>Hypervitaminosis A syndrome</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-brands-1"> <span id="mw-reference-text-cite_note-brands-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/isotretinoin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/isotretinoin.html'" tppabs="https://www.drugs.com/international/isotretinoin.html" class="external text external">"Isotretinoin international brands"</a>. Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">1 June</span> 2017</span>.</cite></span></li><li id="cite_note-Fis2006-2"> <span id="mw-reference-text-cite_note-Fis2006-2" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer J, Ganellin CR (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA476  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA476'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA476" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>476. ISBN<span>&nbsp;</span><bdi>978-3-527-60749-5</bdi>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.mayoclinic.org/drugs-supplements/isotretinoin-oral-route/description/drg-20068178  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.mayoclinic.org/drugs-supplements/isotretinoin-oral-route/description/drg-20068178'" tppabs="https://www.mayoclinic.org/drugs-supplements/isotretinoin-oral-route/description/drg-20068178" class="external text external">"Isotretinoin (Oral Route) Description and Brand Names - Mayo Clinic"</a>.</cite></span></li><li id="cite_note-pmid19588674-4"> <span id="mw-reference-text-cite_note-pmid19588674-4" class="mw-reference-text"><cite id="CITEREFMerrittBurkhartMorrell2009" class="citation journal cs1">Merritt B, Burkhart CN, Morrell DS (June 2009). "Use of isotretinoin for acne vulgaris". <i>Pediatric Annals</i>. <b>38</b> (6): 311–20. doi:<a href="javascript:if(confirm('https://doi.org/10.3928%2F00904481-20090512-01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3928%2F00904481-20090512-01'" tppabs="https://doi.org/10.3928%2F00904481-20090512-01" class="external text external">10.3928/00904481-20090512-01</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19588674  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19588674'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19588674" class="external text external">19588674</a>.</cite></span></li><li id="cite_note-pmid20436884-5"> <span id="mw-reference-text-cite_note-pmid20436884-5" class="mw-reference-text"><cite id="CITEREFLayton2009" class="citation journal cs1">Layton A (May 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909" class="external text external">"The use of isotretinoin in acne"</a>. <i>Dermato-Endocrinology</i>. <b>1</b> (3): 162–9. doi:<a href="javascript:if(confirm('https://doi.org/10.4161%2Fderm.1.3.9364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4161%2Fderm.1.3.9364'" tppabs="https://doi.org/10.4161%2Fderm.1.3.9364" class="external text external">10.4161/derm.1.3.9364</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835909" class="external text external">2835909</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20436884  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20436884'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20436884" class="external text external">20436884</a>.</cite></span></li><li id="cite_note-UKLabel2015-6"> <span id="mw-reference-text-cite_note-UKLabel2015-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/21511  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/21511'" tppabs="https://www.medicines.org.uk/emc/medicine/21511" class="external text external">"Roaccutane 20mg Soft Capsules - Summary of Product Characteristics"</a>. UK Electronic Medicines Compendium. 1 July 2015.</cite></span></li><li id="cite_note-USlabel2010-7"> <span id="mw-reference-text-cite_note-USlabel2010-7" class="mw-reference-text"><cite class="citation report cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s060lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s060lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s060lbl.pdf" class="external text external">US Label</a> <span class="cs1-format">(PDF)</span> (Report). FDA. 22 October 2010 [January 2010]<span class="reference-accessdate">. Retrieved <span class="nowrap">1 June</span> 2017</span>.</cite> See <a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018662  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018662'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018662" class="external text external">FDA Index page for NDA 018662</a> for updates</span></li><li id="cite_note-pmid17276540-8"> <span id="mw-reference-text-cite_note-pmid17276540-8" class="mw-reference-text"><cite id="CITEREFStraussKrowchukLeydenLucky2007" class="citation journal cs1">Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R (April 2007). "Guidelines of care for acne vulgaris management". <i>Journal of the American Academy of Dermatology</i>. <b>56</b> (4): 651–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2006.08.048  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2006.08.048'" tppabs="https://doi.org/10.1016%2Fj.jaad.2006.08.048" class="external text external">10.1016/j.jaad.2006.08.048</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17276540  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17276540'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17276540" class="external text external">17276540</a>.</cite></span></li><li id="cite_note-:0-9"> <span id="mw-reference-text-cite_note-:0-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/documents/psusa/isotretinoin-oral-formulations-cmdh-scientific-conclusions-grounds-variation-amendments-product/00010488/201611_en.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/documents/psusa/isotretinoin-oral-formulations-cmdh-scientific-conclusions-grounds-variation-amendments-product/00010488/201611_en.pdf'" tppabs="https://www.ema.europa.eu/en/documents/psusa/isotretinoin-oral-formulations-cmdh-scientific-conclusions-grounds-variation-amendments-product/00010488/201611_en.pdf" class="external text external">"Isotretinoin (oral formulations): CMDH scientific conclusions – Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)"</a> <span class="cs1-format">(PDF)</span>. European Medicines Agency. August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2019</span>.</cite></span></li><li id="cite_note-Micromedex-10"> <span id="mw-reference-text-cite_note-Micromedex-10" class="mw-reference-text">Klasco RK, editor. Drugdex system, vol. 128. Greenwood Village (CO): Thomson Micromedex; 2006.</span></li><li id="cite_note-Oral_isotretinoin_Therapy-11"> <span id="mw-reference-text-cite_note-Oral_isotretinoin_Therapy-11" class="mw-reference-text"><cite id="CITEREFGeorgalaKatoulisGeorgalaBozi2004" class="citation journal cs1">Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (June 2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851" class="external text external">"Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial"</a>. <i>Sexually Transmitted Infections</i>. <b>80</b> (3): 216–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fsti.2003.006841  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fsti.2003.006841'" tppabs="https://doi.org/10.1136%2Fsti.2003.006841" class="external text external">10.1136/sti.2003.006841</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1744851" class="external text external">1744851</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15170007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15170007'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15170007" class="external text external">15170007</a>.</cite></span></li><li id="cite_note-Unapproved_Isotretinoin-12"> <span id="mw-reference-text-cite_note-Unapproved_Isotretinoin-12" class="mw-reference-text"><cite id="CITEREFSehgalSrivastavaSardana2006" class="citation journal cs1">Sehgal VN, Srivastava G, Sardana K (June 2006). "Isotretinoin--unapproved indications/uses and dosage: a physician's reference". <i>International Journal of Dermatology</i>. <b>45</b> (6): 772–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-4632.2006.02830.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-4632.2006.02830.x'" tppabs="https://doi.org/10.1111%2Fj.1365-4632.2006.02830.x" class="external text external">10.1111/j.1365-4632.2006.02830.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16796650  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16796650'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16796650" class="external text external">16796650</a>.</cite></span></li><li id="cite_note-Choi2013-13"> <span id="mw-reference-text-cite_note-Choi2013-13" class="mw-reference-text"><cite id="CITEREFChoiKorenNulman2013" class="citation journal cs1">Choi JS, Koren G, Nulman I (March 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257" class="external text external">"Pregnancy and isotretinoin therapy"</a>. <i>Canadian Medical Association Journal</i>. <b>185</b> (5): 411–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1503%2Fcmaj.120729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1503%2Fcmaj.120729'" tppabs="https://doi.org/10.1503%2Fcmaj.120729" class="external text external">10.1503/cmaj.120729</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602257" class="external text external">3602257</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23296582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23296582'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23296582" class="external text external">23296582</a>.</cite></span></li><li id="cite_note-BNF47-14"> <span id="mw-reference-text-cite_note-BNF47-14" class="mw-reference-text"><cite id="CITEREFJoint_Formulary_Committee" class="citation book cs1">Joint Formulary Committee. <i>British National Formulary</i> (47th ed.). London: British Medical Association and Royal Pharmaceutical Society of Great Britain. ISBN<span>&nbsp;</span><bdi>978-0-85369-584-4</bdi>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('http://www.australiandoctor.com.au/news/latest-news/fresh-call-for-gps-to-prescribe-roaccutane  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.australiandoctor.com.au/news/latest-news/fresh-call-for-gps-to-prescribe-roaccutane'" tppabs="http://www.australiandoctor.com.au/news/latest-news/fresh-call-for-gps-to-prescribe-roaccutane" class="external text external">"Fresh call for GPs to prescribe Roaccutane"</a>. <i>AustralianDoctor</i>. 19 June 2012.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text">Specifically, doctors who are fellows of the Australasian College of Dermatologists (FACD); cf. Pharmaceutical Services Branch, <i>Guide to poisons and therapeutic goods legislation for medical practitioners and dentists</i>, Sydney: NSW Department of Health; 2006.</span></li><li id="cite_note-James_1996-17"> <span id="mw-reference-text-cite_note-James_1996-17" class="mw-reference-text"><cite id="CITEREFJames1996" class="citation journal cs1">James M (June 1996). "Isotretinoin for severe acne". <i>Lancet</i>. <b>347</b> (9017): 1749–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2896%2990814-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2896%2990814-4'" tppabs="https://doi.org/10.1016%2FS0140-6736%2896%2990814-4" class="external text external">10.1016/S0140-6736(96)90814-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8656912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8656912'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8656912" class="external text external">8656912</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.medsafe.govt.nz/profs/puarticles/isotretdtb.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medsafe.govt.nz/profs/puarticles/isotretdtb.htm'" tppabs="http://www.medsafe.govt.nz/profs/puarticles/isotretdtb.htm" class="external text external">"Acne, Isotretinoin, and Depression"</a>. MEDSAFE (New Zealand Ministry of Health). June 2013 [June 2005]<span class="reference-accessdate">. Retrieved <span class="nowrap">7 February</span> 2014</span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFThiboutotCockerell2006" class="citation journal cs1">Thiboutot, D. M.; Cockerell, C. J. (1 August 2006). "iPLEDGE: A Report from the Front Lines of Dermatologic Practice". <i>AMA Journal of Ethics</i>. <b>8</b> (8): 524–528. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fvirtualmentor.2006.8.8.pfor1-0608  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fvirtualmentor.2006.8.8.pfor1-0608'" tppabs="https://doi.org/10.1001%2Fvirtualmentor.2006.8.8.pfor1-0608" class="external text external">10.1001/virtualmentor.2006.8.8.pfor1-0608</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1937-7010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1937-7010'" tppabs="https://www.worldcat.org/issn/1937-7010" class="external text external">1937-7010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23234692  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23234692'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23234692" class="external text external">23234692</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFDarves2006" class="citation news cs1">Darves, Bonnie (March 9, 2006). <a href="javascript:if(confirm('https://www.medscape.com/viewarticle/525664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medscape.com/viewarticle/525664'" tppabs="https://www.medscape.com/viewarticle/525664" class="external text external">"Dermatologists Frustrated With Problematic iPledge Program"</a>. <i>Medscape</i>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ipledgeprogram.com/AboutiPLEDGE.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ipledgeprogram.com/AboutiPLEDGE.aspx'" tppabs="https://www.ipledgeprogram.com/AboutiPLEDGE.aspx" class="external text external">"iPledge (About iPledge)"</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094305.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094305.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094305.htm" class="external text external">"Isotretinoin (marketed as Accutane) Capsule Information"</a>. U.S. Food and Drug Administration (FDA). 2018-11-03.</cite></span></li><li id="cite_note-UKlabel-23"> <span id="mw-reference-text-cite_note-UKlabel-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/15655  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/15655'" tppabs="https://www.medicines.org.uk/emc/medicine/15655" class="external text external">"Isotretinoin 20mg capsules - - (eMC)"</a>. <i>www.medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-12-27</span></span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/15655  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/15655'" tppabs="https://www.medicines.org.uk/emc/medicine/15655" class="external text external">"Isotretinoin 20mg capsules - - (eMC)"</a>. <i>www.medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-01-10</span></span>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFDavidHodakLowe1988" class="citation journal cs1">David M, Hodak E, Lowe NJ (1988). "Adverse effects of retinoids". <i>Medical Toxicology and Adverse Drug Experience</i>. <b>3</b> (4): 273–88. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf03259940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf03259940'" tppabs="https://doi.org/10.1007%2Fbf03259940" class="external text external">10.1007/bf03259940</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3054426  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3054426'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3054426" class="external text external">3054426</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFDiGiovanna2001" class="citation journal cs1">DiGiovanna JJ (November 2001). "Isotretinoin effects on bone". <i>Journal of the American Academy of Dermatology</i>. <b>45</b> (5): S176-82. doi:<a href="javascript:if(confirm('https://doi.org/10.1067%2Fmjd.2001.113721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1067%2Fmjd.2001.113721'" tppabs="https://doi.org/10.1067%2Fmjd.2001.113721" class="external text external">10.1067/mjd.2001.113721</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11606950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11606950'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11606950" class="external text external">11606950</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFEllisMadisonPennesMartel1984" class="citation journal cs1">Ellis CN, Madison KC, Pennes DR, Martel W, Voorhees JJ (1984). "Isotretinoin therapy is associated with early skeletal radiographic changes". <i>Journal of the American Academy of Dermatology</i>. <b>10</b> (6): 1024–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0190-9622%2884%2980329-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0190-9622%2884%2980329-1'" tppabs="https://doi.org/10.1016%2FS0190-9622%2884%2980329-1" class="external text external">10.1016/S0190-9622(84)80329-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6588057  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6588057'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6588057" class="external text external">6588057</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.contemporarypediatrics.com/acne/isotretinoin-risks-acne-treatment/page/0/2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.contemporarypediatrics.com/acne/isotretinoin-risks-acne-treatment/page/0/2'" tppabs="https://www.contemporarypediatrics.com/acne/isotretinoin-risks-acne-treatment/page/0/2" class="external text external">"Isotretinoin risks in acne treatment: Page 3 of 4"</a>. October 2014.</cite></span></li><li id="cite_note-Moy2015rev-29"> <span id="mw-reference-text-cite_note-Moy2015rev-29" class="mw-reference-text"><cite id="CITEREFMoyMcNamaraLin2015" class="citation journal cs1">Moy A, McNamara NA, Lin MC (September 2015). <a href="javascript:if(confirm('http://www.escholarship.org/uc/item/41k4v4h1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.escholarship.org/uc/item/41k4v4h1'" tppabs="http://www.escholarship.org/uc/item/41k4v4h1" class="external text external">"Effects of Isotretinoin on Meibomian Glands"</a>. <i>Optometry and Vision Science</i>. <b>92</b> (9): 925–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FOPX.0000000000000656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FOPX.0000000000000656'" tppabs="https://doi.org/10.1097%2FOPX.0000000000000656" class="external text external">10.1097/OPX.0000000000000656</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26154692  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26154692'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26154692" class="external text external">26154692</a>.</cite></span></li><li id="cite_note-Lambert_1989-30"> <span id="mw-reference-text-cite_note-Lambert_1989-30" class="mw-reference-text"><cite id="CITEREFLambertSmith1989" class="citation journal cs1">Lambert RW, Smith RE (March 1989). <a href="javascript:if(confirm('https://doi.org/10.1111/1523-1747.ep12277122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111/1523-1747.ep12277122'" tppabs="https://doi.org/10.1111/1523-1747.ep12277122" class="external text external">"Effects of 13-cis-retinoic acid on the hamster meibomian gland"</a>. <i>The Journal of Investigative Dermatology</i>. <b>92</b> (3): 321–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1111%2F1523-1747.ep12277122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2F1523-1747.ep12277122'" tppabs="https://doi.org/10.1111%2F1523-1747.ep12277122" class="external text external">10.1111/1523-1747.ep12277122</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2918239  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2918239'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2918239" class="external text external">2918239</a>.</cite></span></li><li id="cite_note-autogenerated299-31"> <span id="mw-reference-text-cite_note-autogenerated299-31" class="mw-reference-text"><cite id="CITEREFFraunfelderFraunfelderEdwards2001" class="citation journal cs1">Fraunfelder FT, Fraunfelder FW, Edwards R (September 2001). "Ocular side effects possibly associated with isotretinoin usage". <i>American Journal of Ophthalmology</i>. <b>132</b> (3): 299–305. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9394%2801%2901024-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9394%2801%2901024-8'" tppabs="https://doi.org/10.1016%2FS0002-9394%2801%2901024-8" class="external text external">10.1016/S0002-9394(01)01024-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11530040  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11530040'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11530040" class="external text external">11530040</a>.</cite></span></li><li id="cite_note-Brelsford2008rev-32"> <span id="mw-reference-text-cite_note-Brelsford2008rev-32" class="mw-reference-text"><cite id="CITEREFBrelsfordBeute2008" class="citation journal cs1">Brelsford M, Beute TC (September 2008). <a href="javascript:if(confirm('https://zenodo.org/record/1259359  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1259359'" tppabs="https://zenodo.org/record/1259359" class="external text external">"Preventing and managing the side effects of isotretinoin"</a>. <i>Seminars in Cutaneous Medicine and Surgery</i>. <b>27</b> (3): 197–206. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.sder.2008.07.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.sder.2008.07.002'" tppabs="https://doi.org/10.1016%2Fj.sder.2008.07.002" class="external text external">10.1016/j.sder.2008.07.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18786498  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18786498'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18786498" class="external text external">18786498</a>.</cite></span></li><li id="cite_note-pmid16703787-33"> <span id="mw-reference-text-cite_note-pmid16703787-33" class="mw-reference-text"><cite id="CITEREFScheinfeldBangalore2006" class="citation journal cs1">Scheinfeld N, Bangalore S (May 2006). "Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin". <i>Journal of Drugs in Dermatology</i>. <b>5</b> (5): 467–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16703787  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16703787'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16703787" class="external text external">16703787</a>.</cite></span></li><li id="cite_note-:2-34"> <span id="mw-reference-text-cite_note-:2-34" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/referrals/retinoid-containing-medicinal-products  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/referrals/retinoid-containing-medicinal-products'" tppabs="https://www.ema.europa.eu/en/medicines/human/referrals/retinoid-containing-medicinal-products" class="external text external">"Updated measures for pregnancy prevention during retinoid use"</a>. <i>European Medicines Agency</i>. 21 June 2018.</cite></span></li><li id="cite_note-RoaccutanePI-35"> <span id="mw-reference-text-cite_note-RoaccutanePI-35" class="mw-reference-text">Roche Products Pty Ltd. Roaccutane (Australian Approved Product Information). Dee Why (NSW): Roche; 2005.</span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFLeydenDel_RossoBaum2014" class="citation journal cs1">Leyden JJ, Del Rosso JQ, Baum EW (February 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835" class="external text external">"The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions"</a>. <i>The Journal of Clinical and Aesthetic Dermatology</i>. <b>7</b> (2 Suppl): S3–S21. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970835" class="external text external">3970835</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24688620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24688620'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24688620" class="external text external">24688620</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text">BNF, edition 57</span></li><li id="cite_note-Bremner2012rev-38"> <span id="mw-reference-text-cite_note-Bremner2012rev-38" class="mw-reference-text"><cite id="CITEREFBremnerShearerMcCaffery2012" class="citation journal cs1">Bremner JD, Shearer KD, McCaffery PJ (January 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276716  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276716'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276716" class="external text external">"Retinoic acid and affective disorders: the evidence for an association"</a>. <i>The Journal of Clinical Psychiatry</i> (Systematic Review). <b>73</b> (1): 37–50. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2FJCP.10r05993  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2FJCP.10r05993'" tppabs="https://doi.org/10.4088%2FJCP.10r05993" class="external text external">10.4088/JCP.10r05993</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276716  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276716'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276716" class="external text external">3276716</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21903028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21903028'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21903028" class="external text external">21903028</a>.</cite></span></li><li id="cite_note-Kontaxakis2009rev-39"> <span id="mw-reference-text-cite_note-Kontaxakis2009rev-39" class="mw-reference-text"><cite id="CITEREFKontaxakisSkouridesFerentinosHavaki-Kontaxaki2009" class="citation journal cs1">Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN (January 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637283'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637283" class="external text external">"Isotretinoin and psychopathology: a review"</a>. <i>Annals of General Psychiatry</i>. <b>8</b>: 2. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1186%2F1744-859X-8-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1744-859X-8-2'" tppabs="https://doi.org/10.1186%2F1744-859X-8-2" class="external text external">10.1186/1744-859X-8-2</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637283'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637283" class="external text external">2637283</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19154613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19154613'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19154613" class="external text external">19154613</a>.</cite></span></li><li id="cite_note-Borovaya2013rev-40"> <span id="mw-reference-text-cite_note-Borovaya2013rev-40" class="mw-reference-text"><cite id="CITEREFBorovayaOlisovaRuzickaSárdy2013" class="citation journal cs1">Borovaya A, Olisova O, Ruzicka T, Sárdy M (September 2013). "Does isotretinoin therapy of acne cure or cause depression?". <i>International Journal of Dermatology</i>. <b>52</b> (9): 1040–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fijd.12169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fijd.12169'" tppabs="https://doi.org/10.1111%2Fijd.12169" class="external text external">10.1111/ijd.12169</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23962262  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23962262'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23962262" class="external text external">23962262</a>.</cite></span></li><li id="cite_note-MHRAreport-41"> <span id="mw-reference-text-cite_note-MHRAreport-41" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000285965613.zip&agency=MHRA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000285965613.zip&agency=MHRA'" tppabs="https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000285965613.zip&agency=MHRA" class="external text external">"Interactive Drug Analysis Profile - Isotretinoin"</a>. <i>mhra.gov.uk</i>. Medicines &amp; Healthcare Products Regulatory Agency. 31 March 2017.</cite></span></li><li id="cite_note-bjd2010-42"> <span id="mw-reference-text-cite_note-bjd2010-42" class="mw-reference-text"><cite id="CITEREFGoodfieldCoxBowserMcMillan2010" class="citation journal cs1">Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD (June 2010). <a href="javascript:if(confirm('https://doi.org/10.1111/j.1365-2133.2010.09836.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111/j.1365-2133.2010.09836.x'" tppabs="https://doi.org/10.1111/j.1365-2133.2010.09836.x" class="external text external">"Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010"</a>. <i>The British Journal of Dermatology</i>. <b>162</b> (6): 1172–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2133.2010.09836.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2133.2010.09836.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2133.2010.09836.x" class="external text external">10.1111/j.1365-2133.2010.09836.x</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21250961  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21250961'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21250961" class="external text external">21250961</a>.</cite></span></li><li id="cite_note-:1-43"> <span id="mw-reference-text-cite_note-:1-43" class="mw-reference-text"><cite id="CITEREFLudotMouchabacFerreri2015" class="citation journal cs1">Ludot M, Mouchabac S, Ferreri F (June 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473493'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473493" class="external text external">"Inter-relationships between isotretinoin treatment and psychiatric disorders: Depression, bipolar disorder, anxiety, psychosis and suicide risks"</a>. <i>World Journal of Psychiatry</i>. <b>5</b> (2): 222–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.5498%2Fwjp.v5.i2.222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5498%2Fwjp.v5.i2.222'" tppabs="https://doi.org/10.5498%2Fwjp.v5.i2.222" class="external text external">10.5498/wjp.v5.i2.222</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473493'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473493" class="external text external">4473493</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26110123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26110123'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26110123" class="external text external">26110123</a>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFWysowskiPittsBeitz2001" class="citation journal cs1">Wysowski DK, Pitts M, Beitz J (October 2001). <a href="javascript:if(confirm('https://zenodo.org/record/1236038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1236038'" tppabs="https://zenodo.org/record/1236038" class="external text external">"An analysis of reports of depression and suicide in patients treated with isotretinoin"</a>. <i>Journal of the American Academy of Dermatology</i>. <b>45</b> (4): 515–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1067%2Fmjd.2001.117730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1067%2Fmjd.2001.117730'" tppabs="https://doi.org/10.1067%2Fmjd.2001.117730" class="external text external">10.1067/mjd.2001.117730</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11568740  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11568740'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11568740" class="external text external">11568740</a>.</cite></span></li><li id="cite_note-Rowe2014-45"> <span id="mw-reference-text-cite_note-Rowe2014-45" class="mw-reference-text"><cite id="CITEREFRoweSpelmanOziemskiRyan2014" class="citation journal cs1">Rowe C, Spelman L, Oziemski M, Ryan A, Manoharan S, Wilson P, Daubney M, Scott J (May 2014). "Isotretinoin and mental health in adolescents: Australian consensus". <i>The Australasian Journal of Dermatology</i> (Review). <b>55</b> (2): 162–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fajd.12117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fajd.12117'" tppabs="https://doi.org/10.1111%2Fajd.12117" class="external text external">10.1111/ajd.12117</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24283385  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24283385'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24283385" class="external text external">24283385</a>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFPalhaGoodman2006" class="citation journal cs1">Palha JA, Goodman AB (June 2006). <a href="javascript:if(confirm('http://repositorium.sdum.uminho.pt/bitstream/1822/3943/1/Palha%20and%20Goodman%202005%20BRR.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://repositorium.sdum.uminho.pt/bitstream/1822/3943/1/Palha%20and%20Goodman%202005%20BRR.pdf'" tppabs="http://repositorium.sdum.uminho.pt/bitstream/1822/3943/1/Palha%20and%20Goodman%202005%20BRR.pdf" class="external text external">"Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia"</a> <span class="cs1-format">(PDF)</span>. <i>Brain Research Reviews</i>. <b>51</b> (1): 61–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.brainresrev.2005.10.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.brainresrev.2005.10.001'" tppabs="https://doi.org/10.1016%2Fj.brainresrev.2005.10.001" class="external text external">10.1016/j.brainresrev.2005.10.001</a>. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/1822%2F3943  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/1822%2F3943'" tppabs="https://hdl.handle.net/1822%2F3943" class="external text external">1822/3943</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16325258  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16325258'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16325258" class="external text external">16325258</a>.</cite></span></li><li id="cite_note-:3-47"> <span id="mw-reference-text-cite_note-:3-47" class="mw-reference-text"><cite id="CITEREFGoodman1994" class="citation journal cs1">Goodman AB (March 1994). "Retinoid dysregulation as a cause of schizophrenia". <i>The American Journal of Psychiatry</i>. <b>151</b> (3): 452–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1176%2Fajp.151.3.452b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1176%2Fajp.151.3.452b'" tppabs="https://doi.org/10.1176%2Fajp.151.3.452b" class="external text external">10.1176/ajp.151.3.452b</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8109664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8109664'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8109664" class="external text external">8109664</a>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite id="CITEREFGoodman1996" class="citation journal cs1">Goodman AB (May 1996). "Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology". <i>Schizophrenia Research</i>. <b>19</b> (2–3): 163–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0920-9964%2896%2988523-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0920-9964%2896%2988523-9'" tppabs="https://doi.org/10.1016%2F0920-9964%2896%2988523-9" class="external text external">10.1016/0920-9964(96)88523-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8789914  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8789914'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8789914" class="external text external">8789914</a>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite id="CITEREFGoodman2005" class="citation journal cs1">Goodman AB (July 2005). <a href="javascript:if(confirm('https://doi.org/10.1038/sj.mp.4001668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038/sj.mp.4001668'" tppabs="https://doi.org/10.1038/sj.mp.4001668" class="external text external">"Microarray results suggest altered transport and lowered synthesis of retinoic acid in schizophrenia"</a>. <i>Molecular Psychiatry</i>. <b>10</b> (7): 620–1. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.mp.4001668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.mp.4001668'" tppabs="https://doi.org/10.1038%2Fsj.mp.4001668" class="external text external">10.1038/sj.mp.4001668</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15838536  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15838536'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15838536" class="external text external">15838536</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite id="CITEREFSamadKrezelChambonBorrelli1997" class="citation journal cs1">Samad TA, Krezel W, Chambon P, Borrelli E (December 1997). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24972'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24972" class="external text external">"Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>94</b> (26): 14349–54. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1997PNAS...9414349S  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1997PNAS...9414349S'" tppabs="https://ui.adsabs.harvard.edu/abs/1997PNAS...9414349S" class="external text external">1997PNAS...9414349S</a>. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.94.26.14349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.94.26.14349'" tppabs="https://doi.org/10.1073%2Fpnas.94.26.14349" class="external text external">10.1073/pnas.94.26.14349</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24972'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24972" class="external text external">24972</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9405615  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9405615'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9405615" class="external text external">9405615</a>.</cite></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><cite id="CITEREFCrockettPorterMartinSandler2010" class="citation journal cs1">Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD (September 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620" class="external text external">"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study"</a>. <i>The American Journal of Gastroenterology</i>. <b>105</b> (9): 1986–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fajg.2010.124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fajg.2010.124'" tppabs="https://doi.org/10.1038%2Fajg.2010.124" class="external text external">10.1038/ajg.2010.124</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073620" class="external text external">3073620</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20354506  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20354506'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20354506" class="external text external">20354506</a>.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFLowensteinLowenstein2011" class="citation journal cs1">Lowenstein EB, Lowenstein EJ (2011). "Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero". <i>Clinics in Dermatology</i>. <b>29</b> (6): 652–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clindermatol.2011.08.026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clindermatol.2011.08.026'" tppabs="https://doi.org/10.1016%2Fj.clindermatol.2011.08.026" class="external text external">10.1016/j.clindermatol.2011.08.026</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22014987  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22014987'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22014987" class="external text external">22014987</a>.</cite></span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/655127/DSU-Oct-pdf.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/655127/DSU-Oct-pdf.pdf'" tppabs="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/655127/DSU-Oct-pdf.pdf" class="external text external">"Drug Safety Update – Latest advice for medicines users – October 2017"</a> <span class="cs1-format">(PDF)</span>. Medicines and Healthcare products Regulatory Agency. 3 October 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2019</span>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-3-6-july-2017_en.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-3-6-july-2017_en.pdf'" tppabs="https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-3-6-july-2017_en.pdf" class="external text external">"Pharmacovigilance Risk Assessment Committee (PRAC) – Minutes for the meeting on 3–6 July 2017"</a> <span class="cs1-format">(PDF)</span>. European Medicines Agency. 1 September 2017. p.<span>&nbsp;</span>44<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2019</span>.</cite></span></li><li id="cite_note-Kremer1994-55"> <span id="mw-reference-text-cite_note-Kremer1994-55" class="mw-reference-text"><cite id="CITEREFKremerGatonDavidGaton1994" class="citation journal cs1">Kremer I, Gaton DD, David M, Gaton E, Shapiro A (1994). "Toxic effects of systemic retinoids on meibomian glands". <i>Ophthalmic Research</i>. <b>26</b> (2): 124–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000267402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000267402'" tppabs="https://doi.org/10.1159%2F000267402" class="external text external">10.1159/000267402</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8196934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8196934'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8196934" class="external text external">8196934</a>.</cite></span></li><li id="cite_note-Griffin_2010-56"> <span id="mw-reference-text-cite_note-Griffin_2010-56" class="mw-reference-text"><cite id="CITEREFGriffinPinaliOldsLu2010" class="citation journal cs1">Griffin JN, Pinali D, Olds K, Lu N, Appleby L, Doan L, Lane MA (November 2010). "13-Cis-retinoic acid decreases hypothalamic cell number in vitro". <i>Neuroscience Research</i>. <b>68</b> (3): 185–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neures.2010.08.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neures.2010.08.003'" tppabs="https://doi.org/10.1016%2Fj.neures.2010.08.003" class="external text external">10.1016/j.neures.2010.08.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20708044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20708044'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20708044" class="external text external">20708044</a>.</cite></span></li><li id="cite_note-Crandall2004-57"> <span id="mw-reference-text-cite_note-Crandall2004-57" class="mw-reference-text"><cite id="CITEREFCrandallSakaiZhangKoul2004" class="citation journal cs1">Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P (April 2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382" class="external text external">"13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>101</b> (14): 5111–6. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2004PNAS..101.5111C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2004PNAS..101.5111C'" tppabs="https://ui.adsabs.harvard.edu/abs/2004PNAS..101.5111C" class="external text external">2004PNAS..101.5111C</a>. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.0306336101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.0306336101'" tppabs="https://doi.org/10.1073%2Fpnas.0306336101" class="external text external">10.1073/pnas.0306336101</a></span>. JSTOR<span>&nbsp;</span><a href="javascript:if(confirm('https://www.jstor.org/stable/3371827  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstor.org/stable/3371827'" tppabs="https://www.jstor.org/stable/3371827" class="external text external">3371827</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382" class="external text external">387382</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15051884  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15051884'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15051884" class="external text external">15051884</a>.</cite></span></li><li id="cite_note-Sakai_2004-58"> <span id="mw-reference-text-cite_note-Sakai_2004-58" class="mw-reference-text"><cite id="CITEREFSakaiCrandallBrodskyMcCaffery2004" class="citation journal cs1">Sakai Y, Crandall JE, Brodsky J, McCaffery P (June 2004). "13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice". <i>Annals of the New York Academy of Sciences</i>. <b>1021</b> (1): 436–40. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2004NYASA1021..436S  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2004NYASA1021..436S'" tppabs="https://ui.adsabs.harvard.edu/abs/2004NYASA1021..436S" class="external text external">2004NYASA1021..436S</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1196%2Fannals.1308.059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1196%2Fannals.1308.059'" tppabs="https://doi.org/10.1196%2Fannals.1308.059" class="external text external">10.1196/annals.1308.059</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15251924  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15251924'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15251924" class="external text external">15251924</a>.</cite></span></li><li id="cite_note-Nelson2011-59"> <span id="mw-reference-text-cite_note-Nelson2011-59" class="mw-reference-text"><cite id="CITEREFNelsonCongGillilandThiboutot2011" class="citation journal cs1">Nelson AM, Cong Z, Gilliland KL, Thiboutot DM (September 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444" class="external text external">"TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells"</a>. <i>The British Journal of Dermatology</i>. <b>165</b> (3): 526–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2133.2011.10392.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2133.2011.10392.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2133.2011.10392.x" class="external text external">10.1111/j.1365-2133.2011.10392.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166444" class="external text external">3166444</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21564055  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21564055'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21564055" class="external text external">21564055</a>.</cite></span></li><li id="cite_note-Nelson_2006-60"> <span id="mw-reference-text-cite_note-Nelson_2006-60" class="mw-reference-text"><cite id="CITEREFNelsonGillilandCongThiboutot2006" class="citation journal cs1">Nelson AM, Gilliland KL, Cong Z, Thiboutot DM (October 2006). <a href="javascript:if(confirm('https://doi.org/10.1038/sj.jid.5700289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038/sj.jid.5700289'" tppabs="https://doi.org/10.1038/sj.jid.5700289" class="external text external">"13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes"</a>. <i>The Journal of Investigative Dermatology</i>. <b>126</b> (10): 2178–89. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.jid.5700289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.jid.5700289'" tppabs="https://doi.org/10.1038%2Fsj.jid.5700289" class="external text external">10.1038/sj.jid.5700289</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16575387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16575387'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16575387" class="external text external">16575387</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFWachter_K2009" class="citation journal cs1">Wachter K (2009). "Isotretinoin's Mechanism of Action Explored". <i>Skin &amp; Allergy News</i>. <b>40</b> (11): 32. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0037-6337%2809%2970553-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0037-6337%2809%2970553-4'" tppabs="https://doi.org/10.1016%2FS0037-6337%2809%2970553-4" class="external text external">10.1016/S0037-6337(09)70553-4</a>.</cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><a href="javascript:if(confirm('http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx'" tppabs="http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx" class="external text external">Isotretinoin’s Mechanism of Action Elucidated</a> <a href="javascript:if(confirm('https://web.archive.org/web/20100404060010/http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100404060010/http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx'" tppabs="https://web.archive.org/web/20100404060010/http://www.medconnect.com.au/tabid/84/ct1/c333004/Isotretinoin-s-Mechanism-of-Action-Elucidated/Default.aspx" class="external text external">Archived</a><span> 2010-04-04 at the </span>Wayback Machine. Medconnect (2009-08-28). Retrieved on 2010-11-13.</span></li><li id="cite_note-pmid18317594-63"> <span id="mw-reference-text-cite_note-pmid18317594-63" class="mw-reference-text"><cite id="CITEREFNelsonZhaoGillilandZaenglein2008" class="citation journal cs1">Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM (April 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030" class="external text external">"Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells"</a>. <i>The Journal of Clinical Investigation</i>. <b>118</b> (4): 1468–78. doi:<a href="javascript:if(confirm('https://doi.org/10.1172%2FJCI33869  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1172%2FJCI33869'" tppabs="https://doi.org/10.1172%2FJCI33869" class="external text external">10.1172/JCI33869</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262030" class="external text external">2262030</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18317594  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18317594'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18317594" class="external text external">18317594</a>.</cite></span></li><li id="cite_note-Peck-64"> <span id="mw-reference-text-cite_note-Peck-64" class="mw-reference-text"><cite id="CITEREFPeckOlsenYoderStrauss1979" class="citation journal cs1">Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, Butkus D, Arnaud-Battandier J (February 1979). "Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid". <i>The New England Journal of Medicine</i>. <b>300</b> (7): 329–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM197902153000701  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM197902153000701'" tppabs="https://doi.org/10.1056%2FNEJM197902153000701" class="external text external">10.1056/NEJM197902153000701</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/153472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/153472'" tppabs="https://pubmed.ncbi.nlm.nih.gov/153472" class="external text external">153472</a>.</cite></span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite id="CITEREFShalita_A2001" class="citation journal cs1">Shalita A (2001). "The integral role of topical and oral retinoids in the early treatment of acne". <i>Journal of the European Academy of Dermatology and Venereology</i>. <b>15</b>: 43–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.0926-9959.2001.00012.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.0926-9959.2001.00012.x'" tppabs="https://doi.org/10.1046%2Fj.0926-9959.2001.00012.x" class="external text external">10.1046/j.0926-9959.2001.00012.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11843233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11843233'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11843233" class="external text external">11843233</a>.</cite></span></li><li id="cite_note-Farrell-66"> <span id="mw-reference-text-cite_note-Farrell-66" class="mw-reference-text"><cite id="CITEREFFarrellStraussStranieri1980" class="citation journal cs1">Farrell LN, Strauss JS, Stranieri AM (December 1980). "The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial". <i>Journal of the American Academy of Dermatology</i>. <b>3</b> (6): 602–11. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0190-9622%2880%2980074-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0190-9622%2880%2980074-0'" tppabs="https://doi.org/10.1016%2FS0190-9622%2880%2980074-0" class="external text external">10.1016/S0190-9622(80)80074-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6451637  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6451637'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6451637" class="external text external">6451637</a>.</cite></span></li><li id="cite_note-Jones-67"> <span id="mw-reference-text-cite_note-Jones-67" class="mw-reference-text"><cite id="CITEREFJonesBlancCunliffe1980" class="citation journal cs1">Jones H, Blanc D, Cunliffe WJ (November 1980). "13-cis retinoic acid and acne". <i>Lancet</i>. <b>2</b> (8203): 1048–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2880%2992273-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2880%2992273-4'" tppabs="https://doi.org/10.1016%2FS0140-6736%2880%2992273-4" class="external text external">10.1016/S0140-6736(80)92273-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6107678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6107678'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6107678" class="external text external">6107678</a>.</cite></span></li><li id="cite_note-Pendino-68"> <span id="mw-reference-text-cite_note-Pendino-68" class="mw-reference-text"><cite id="CITEREFPendinoFlexorDelhommeauBuet2001" class="citation journal cs1">Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E (June 2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34517  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34517'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34517" class="external text external">"Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>98</b> (12): 6662–7. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2001PNAS...98.6662P  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2001PNAS...98.6662P'" tppabs="https://ui.adsabs.harvard.edu/abs/2001PNAS...98.6662P" class="external text external">2001PNAS...98.6662P</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.111464998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.111464998'" tppabs="https://doi.org/10.1073%2Fpnas.111464998" class="external text external">10.1073/pnas.111464998</a>. JSTOR<span>&nbsp;</span><a href="javascript:if(confirm('https://www.jstor.org/stable/3055868  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstor.org/stable/3055868'" tppabs="https://www.jstor.org/stable/3055868" class="external text external">3055868</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34517  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34517'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34517" class="external text external">34517</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11371621  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11371621'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11371621" class="external text external">11371621</a>.</cite></span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text"><cite id="CITEREFΦαχαντίδης2007" class="citation book cs1">Φαχαντίδης, Παναγιώτης Ε. (2007). <a href="javascript:if(confirm('http://invenio.lib.auth.gr/record/103970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://invenio.lib.auth.gr/record/103970'" tppabs="http://invenio.lib.auth.gr/record/103970" class="external text external"><bdi lang="el">Η επίδραση της ισοτρετινοϊνης και των αναστολέων της 5α-αναγωγάσης στις μεταλλοπρωτεάσες του συνδετικού ιστού σε ασθενείς με ακμή</bdi></a> <span>[</span><i>The influence of isotretinoin and 5-a reductase inhibitors in metaloproteases of connective tissue in patients with ance</i><span>]</span> (in Greek). Aristotle University of Thessaloniki.</cite></span></li><li id="cite_note-pmid12102663-70"> <span id="mw-reference-text-cite_note-pmid12102663-70" class="mw-reference-text"><cite id="CITEREFToyodaNakamuraMakinoKagoura2002" class="citation journal cs1">Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M (June 2002). "Sebaceous glands in acne patients express high levels of neutral endopeptidase". <i>Experimental Dermatology</i>. <b>11</b> (3): 241–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1034%2Fj.1600-0625.2002.110307.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1034%2Fj.1600-0625.2002.110307.x'" tppabs="https://doi.org/10.1034%2Fj.1600-0625.2002.110307.x" class="external text external">10.1034/j.1600-0625.2002.110307.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12102663  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12102663'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12102663" class="external text external">12102663</a>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite id="CITEREFWysowskiSwartz2005" class="citation journal cs1">Wysowski DK, Swartz L (May 2005). "Relationship between headache and depression in users of isotretinoin". <i>Archives of Dermatology</i>. <b>141</b> (5): 640–1. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchderm.141.5.640  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchderm.141.5.640'" tppabs="https://doi.org/10.1001%2Farchderm.141.5.640" class="external text external">10.1001/archderm.141.5.640</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15897395  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15897395'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15897395" class="external text external">15897395</a>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text"><cite id="CITEREFMaginPondSmith2005" class="citation journal cs1">Magin P, Pond D, Smith W (February 2005). <a href="javascript:if(confirm('http://bjgp.org/content/55/511/134  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://bjgp.org/content/55/511/134'" tppabs="http://bjgp.org/content/55/511/134" class="external text external">"Isotretinoin, depression and suicide: a review of the evidence"</a>. <i>The British Journal of General Practice</i>. <b>55</b> (511): 134–8. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463189  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463189'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463189" class="external text external">1463189</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15720936  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15720936'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15720936" class="external text external">15720936</a>.</cite></span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text"><cite id="CITEREFNgSchweitzer2003" class="citation journal cs1">Ng CH, Schweitzer I (February 2003). "The association between depression and isotretinoin use in acne". <i>The Australian and New Zealand Journal of Psychiatry</i>. <b>37</b> (1): 78–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1440-1614.2003.01111.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1440-1614.2003.01111.x'" tppabs="https://doi.org/10.1046%2Fj.1440-1614.2003.01111.x" class="external text external">10.1046/j.1440-1614.2003.01111.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12534661  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12534661'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12534661" class="external text external">12534661</a>.</cite></span></li><li id="cite_note-drugs.com-74"> <span id="mw-reference-text-cite_note-drugs.com-74" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pro/accutane.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pro/accutane.html'" tppabs="https://www.drugs.com/pro/accutane.html" class="external text external">"FDA information, side effects, and uses / Accutane (isotretinoin)"</a>. U. S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2014</span>.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pro/accutane.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pro/accutane.html#T_2'" tppabs="https://www.drugs.com/pro/accutane.html#T_2" class="external text external">"FDA information, side effects, and uses / Accutane (isotretinoin)<span>&nbsp;</span>: <b>Table 2 Pharmacokinetic Parameters of Isotretinoin Mean (%CV), N=74</b>"</a>. U. S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2014</span>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pro/accutane.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pro/accutane.html#Drug_Interactions'" tppabs="https://www.drugs.com/pro/accutane.html#Drug_Interactions" class="external text external">"FDA information, side effects, and uses / Accutane (isotretinoin)<span>&nbsp;</span>: <b>Drug Interactions</b>"</a>. U. S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2014</span>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text">Gina Kolata for the New York Times. April 22, 1988 <a href="javascript:if(confirm('https://www.nytimes.com/1988/04/22/us/anti-acne-drug-faulted-in-birth-defects.html?pagewanted=all  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1988/04/22/us/anti-acne-drug-faulted-in-birth-defects.html?pagewanted=all'" tppabs="https://www.nytimes.com/1988/04/22/us/anti-acne-drug-faulted-in-birth-defects.html?pagewanted=all" class="external text external">Anti-Acne Drug Faulted in Birth</a></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text">CDC. January 21, 2000 <a href="javascript:if(confirm('https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4902a2.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4902a2.htm'" tppabs="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4902a2.htm" class="external text external">Accutane®-Exposed Pregnancies -- California, 1999</a> MMWR Weekly 49(02);28-31</span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><cite id="CITEREFShari_Roan2009" class="citation web cs1">Shari Roan (7 November 2009). <a href="javascript:if(confirm('http://www.latimes.com/nation/la-sci-accutane7-2009nov07-story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.latimes.com/nation/la-sci-accutane7-2009nov07-story.html#page=1'" tppabs="http://www.latimes.com/nation/la-sci-accutane7-2009nov07-story.html#page=1" class="external text external">"New study may deal final blow to acne drug Accutane"</a>. LA Times.</cite></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20091108053218/http://www.gene.com/gene/products/information/accutane/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20091108053218/http://www.gene.com/gene/products/information/accutane/'" tppabs="https://web.archive.org/web/20091108053218/http://www.gene.com/gene/products/information/accutane/" class="external text external">"Roche Discontinues and Plans to Delist Accutane in the U.S."</a> (Press release). Genentech. 2009-06-29. Archived from <a href="javascript:if(confirm('http://www.gene.com/gene/products/information/accutane/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.gene.com/gene/products/information/accutane/'" tppabs="http://www.gene.com/gene/products/information/accutane/" class="external text external">the original</a> on 2009-11-08<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-12</span></span>.</cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite id="CITEREFFeeley_J2011" class="citation news cs1">Feeley J (2011-03-11). <a href="javascript:if(confirm('https://www.bloomberg.com/news/2011-03-10/roche-s-accutane-caused-tragedy-for-actor-brian-dennehy-says.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/news/2011-03-10/roche-s-accutane-caused-tragedy-for-actor-brian-dennehy-says.html'" tppabs="https://www.bloomberg.com/news/2011-03-10/roche-s-accutane-caused-tragedy-for-actor-brian-dennehy-says.html" class="external text external">"Roche Accutane Acne Drug Caused 'Tragedy' for Actor, Brian Dennehy Says"</a>. <i>Bloomberg</i>.</cite></span></li><li id="cite_note-urlIts_Curtains_On_Actors_Accutane_Lawsuit_|_Pharmalot-82"> <span id="mw-reference-text-cite_note-urlIts_Curtains_On_Actors_Accutane_Lawsuit_|_Pharmalot-82" class="mw-reference-text"><cite id="CITEREFSilverman_E2011" class="citation web cs1">Silverman E (2011-11-04). <a href="javascript:if(confirm('http://www.pharmalive.com/its-curtains-actors-accutane-lawsuit  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharmalive.com/its-curtains-actors-accutane-lawsuit'" tppabs="http://www.pharmalive.com/its-curtains-actors-accutane-lawsuit" class="external text external">"It's Curtains On Actor's Accutane Lawsuit"</a>. <i>Pharmalot</i>. UBM Canon.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite id="CITEREFVoreacos_D2007" class="citation news cs1">Voreacos D (May 30, 2007). <a href="javascript:if(confirm('https://www.washingtonpost.com/wp-dyn/content/article/2007/05/29/AR2007052901946.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.washingtonpost.com/wp-dyn/content/article/2007/05/29/AR2007052901946.html'" tppabs="https://www.washingtonpost.com/wp-dyn/content/article/2007/05/29/AR2007052901946.html" class="external text external">"Roche Found Liable in First Of 400 Suits Over Accutane"</a>. <i>The Washington Post</i>. Bloomberg News<span class="reference-accessdate">. Retrieved <span class="nowrap">April 30,</span> 2012</span>.</cite></span></li><li id="cite_note-84"> <span id="mw-reference-text-cite_note-84" class="mw-reference-text"><cite id="CITEREFHalverstamZeichnerLebwohl2006" class="citation journal cs1">Halverstam CP, Zeichner J, Lebwohl M (2006). "Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature". <i>Journal of Cutaneous Medicine and Surgery</i>. <b>10</b> (6): 291–9. doi:<a href="javascript:if(confirm('https://doi.org/10.2310%2F7750.2006.00065  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2310%2F7750.2006.00065'" tppabs="https://doi.org/10.2310%2F7750.2006.00065" class="external text external">10.2310/7750.2006.00065</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17241599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17241599'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17241599" class="external text external">17241599</a>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://www.drugs.com/MTM/isotretinoin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/MTM/isotretinoin.html'" tppabs="https://www.drugs.com/MTM/isotretinoin.html" class="external text external">Drugs.com Isotretinoin Information</a></li>
<li>DermNet <i><a href="javascript:if(confirm('https://www.dermnetnz.org/treatments/isotretinoin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.dermnetnz.org/treatments/isotretinoin.html'" tppabs="https://www.dermnetnz.org/treatments/isotretinoin.html" class="external text external">treatments/isotretinoin</a></i></li></ul><span>
</span>

<div role="navigation" class="navbox" aria-labelledby="Carotenoids" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Carotenoids" style="font-size:114%;margin:0 4em">Carotenoids</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Carotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Carotene" title="Carotene">Carotenes</a> (C<sub>40</sub>)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alpha-Carotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Carotene" title="Alpha-Carotene">α-Carotene</a></li>
<li><a href="Beta-Carotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Beta-Carotene" title="Beta-Carotene">β-Carotene</a></li>
<li>γ-Carotene</li>
<li><a href="Delta-Carotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Delta-Carotene" title="Delta-Carotene">δ-Carotene</a></li>
<li><a href="Epsilon-Carotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Epsilon-Carotene" title="Epsilon-Carotene">ε-Carotene</a></li>
<li>ζ-Carotene</li>
<li><a href="Lycopene.htm" tppabs="https://ptable.com/wiki/compounds/A/Lycopene" title="Lycopene">Lycopene</a></li>
<li>Neurosporene</li>
<li><a href="Phytoene.htm" tppabs="https://ptable.com/wiki/compounds/A/Phytoene" title="Phytoene">Phytoene</a></li>
<li><a href="Phytofluene.htm" tppabs="https://ptable.com/wiki/compounds/A/Phytofluene" title="Phytofluene">Phytofluene</a></li>
<li><a href="Torulene.htm" tppabs="https://ptable.com/wiki/compounds/A/Torulene" title="Torulene">Torulene</a></li>
<li><span class="new">Lycopersene</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Xanthophyll.htm" tppabs="https://ptable.com/wiki/compounds/A/Xanthophyll" title="Xanthophyll">Xanthophylls</a> (C<sub>40</sub>)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Antheraxanthin.htm" tppabs="https://ptable.com/wiki/compounds/A/Antheraxanthin" title="Antheraxanthin">Antheraxanthin</a></li>
<li><a href="Astaxanthin.htm" tppabs="https://ptable.com/wiki/compounds/A/Astaxanthin" title="Astaxanthin">Astaxanthin</a></li>
<li><a href="Canthaxanthin.htm" tppabs="https://ptable.com/wiki/compounds/A/Canthaxanthin" title="Canthaxanthin">Canthaxanthin</a></li>
<li>Citranaxanthin</li>
<li><a href="Cryptoxanthin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cryptoxanthin" title="Cryptoxanthin">Cryptoxanthin</a></li>
<li>Diadinoxanthin</li>
<li>Diatoxanthin</li>
<li>Dinoxanthin</li>
<li>Echinenone</li>
<li>Flavoxanthin</li>
<li>Fucoxanthin</li>
<li><a href="Lutein.htm" tppabs="https://ptable.com/wiki/compounds/A/Lutein" title="Lutein">Lutein</a></li>
<li>Neoxanthin</li>
<li>Rhodoxanthin</li>
<li>Rubixanthin</li>
<li><a href="Violaxanthin.htm" tppabs="https://ptable.com/wiki/compounds/A/Violaxanthin" title="Violaxanthin">Violaxanthin</a></li>
<li><a href="Zeaxanthin.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeaxanthin" title="Zeaxanthin">Zeaxanthin</a></li>
<li><span class="new">Zeinoxanthin</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Apocarotenoids (C<sub>&lt;40</sub>)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Abscisic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Abscisic_acid" title="Abscisic acid">Abscisic acid</a></li>
<li><a href="Apocarotenal.htm" tppabs="https://ptable.com/wiki/compounds/A/Apocarotenal" title="Apocarotenal">Apocarotenal</a></li>
<li><a href="Bixin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bixin" title="Bixin">Bixin</a></li>
<li><a href="Crocetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Crocetin" title="Crocetin">Crocetin</a></li>
<li>Food orange 7</li>
<li><a href="Ionone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ionone" title="Ionone">Ionones</a></li>
<li><a href="Peridinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Peridinin" title="Peridinin">Peridinin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vitamin A retinoids (C<sub>20</sub>)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Retinal.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinal" title="Retinal">Retinal</a></li>
<li><a href="Retinoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinoic_acid" title="Retinoic acid">Retinoic acid</a></li>
<li>Retinol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Retinoid drugs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Acitretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Acitretin" title="Acitretin">Acitretin</a></li>
<li><a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="Bexarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Bexarotene" title="Bexarotene">Bexarotene</a></li>
<li><a href="Etretinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etretinate" title="Etretinate">Etretinate</a></li>
<li><a href="Fenretinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenretinide" title="Fenretinide">Fenretinide</a></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li><a href="Tazarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Tazarotene" title="Tazarotene">Tazarotene</a></li>
<li><span class="new">Temarotene</span></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">Tretinoin</a></li>
<li><span class="new">Zuretinol acetate</span></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Acne-treating_agents_(D10)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Acne-treating_agents_(D10)" style="font-size:114%;margin:0 4em">Acne-treating agents (D10)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antibacterial</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Azelaic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Azelaic_acid" title="Azelaic acid">Azelaic acid</a></li>
<li><a href="Benzoyl_peroxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzoyl_peroxide" title="Benzoyl peroxide">Benzoyl peroxide</a><sup>#</sup></li>
<li><a href="8-Hydroxyquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/8-Hydroxyquinoline" title="8-Hydroxyquinoline">8-Hydroxyquinoline</a></li>
<li>Blue light therapy</li>
<li><a href="Tea_tree_oil.htm" tppabs="https://ptable.com/wiki/compounds/A/Tea_tree_oil" title="Tea tree oil">Tea tree oil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Keratolytic</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Glycolic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycolic_acid" title="Glycolic acid">Glycolic acid</a></li>
<li><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylic acid</a><sup>#</sup></li>
<li>Sulfur</li>
<li><a href="Benzoyl_peroxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzoyl_peroxide" title="Benzoyl peroxide">Benzoyl peroxide</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-inflammatory</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Nicotinamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinamide" title="Nicotinamide">Nicotinamide</a></li>
<li><a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">Ibuprofen</a><sup>#</sup></li>
<li><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Aspirin</a><sup>#</sup></li>
<li>Red light therapy</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antibiotics</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li><a href="Dapsone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dapsone" title="Dapsone">Dapsone</a></li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li><a href="Sulfacetamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfacetamide" title="Sulfacetamide">Sulfacetamide</a></li>
<li>Tetracyclines (<a href="Lymecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Lymecycline" title="Lymecycline">Lymecycline</a></li>
<li><a href="Minocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Minocycline" title="Minocycline">Minocycline</a></li>
<li><a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">Doxycycline</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hormonal</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiandrogens
<ul><li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a>)</li></ul></li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogens</a>
<ul><li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li>Ethinylestradiol</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Retinoids</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Adapalene.htm" tppabs="https://ptable.com/wiki/compounds/A/Adapalene" title="Adapalene">Adapalene</a></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li>Motretinide</li>
<li><a href="Tazarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Tazarotene" title="Tazarotene">Tazarotene</a></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">Tretinoin</a></li>
<li>Trifarotene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benzamycin</li>
<li>Epristeride</li>
<li>Mesulfen</li>
<li>Pelretin</li>
<li>Stridex</li>
<li><a href="Tioxolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tioxolone" title="Tioxolone">Tioxolone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Adapalene/benzoyl peroxide</li>
<li>Benzoyl peroxide/clindamycin</li>
<li>Clindamycin/tretinoin</li>
<li>Erythromycin/isotretinoin</li>
<li>Sulfacetamide/sulfur</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Retinoid_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Retinoid_receptor_modulators" style="font-size:114%;margin:0 4em">Retinoid receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>RAR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">9CDHRA</span></li>
<li><a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">9-<i>cis</i>-Retinoic acid (alitretinoin)</a></li>
<li><span class="new">AC-261066</span></li>
<li><span class="new">AC-55649</span></li>
<li><a href="Acitretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Acitretin" title="Acitretin">Acitretin</a></li>
<li><a href="Adapalene.htm" tppabs="https://ptable.com/wiki/compounds/A/Adapalene" title="Adapalene">Adapalene</a></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">all-<i>trans</i>-Retinoic acid (tretinoin)</a></li>
<li><span class="new">AM-580</span></li>
<li><span class="new">BMS-493</span></li>
<li><span class="new">BMS-753</span></li>
<li><span class="new">BMS-961</span></li>
<li><span class="new">CD-1530</span></li>
<li><span class="new">CD-2314</span></li>
<li><span class="new">CD-437</span></li>
<li><span class="new">Ch-55</span></li>
<li><span class="new">EC 23</span></li>
<li><a href="Etretinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etretinate" title="Etretinate">Etretinate</a></li>
<li><a href="Fenretinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenretinide" title="Fenretinide">Fenretinide</a></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li>Palovarotene</li>
<li><a href="Retinoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinoic_acid" title="Retinoic acid">Retinoic acid</a></li>
<li>Retinol (<a href="Vitamin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_A" title="Vitamin A">vitamin A</a>)</li>
<li><a href="Tamibarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamibarotene" title="Tamibarotene">Tamibarotene</a></li>
<li><a href="Tazarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Tazarotene" title="Tazarotene">Tazarotene</a></li>
<li><span class="new">Tazarotenic acid</span></li>
<li><span class="new">TTNPB</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">BMS-195614</span></li>
<li><span class="new">BMS-493</span></li>
<li><span class="new">CD-2665</span></li>
<li><span class="new">ER-50891</span></li>
<li><span class="new">LE-135</span></li>
<li><span class="new">MM-11253</span></li></ul>

<ul><li><i>Retinoic acid metabolism inhibitors:</i> Liarozole</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>RXR</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">9CDHRA</span></li>
<li><a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">9-<i>cis</i>-Retinoic acid (alitretinoin)</a></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">all-<i>trans</i>-Retinoic acid (tretinoin)</a></li>
<li><a href="Bexarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Bexarotene" title="Bexarotene">Bexarotene</a></li>
<li><span class="new">CD 3254</span></li>
<li><a href="Docosahexaenoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Docosahexaenoic_acid" title="Docosahexaenoic acid">Docosahexaenoic acid</a></li>
<li><span class="new">Fluorobexarotene</span></li>
<li><a href="Isotretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li>
<li><span class="new">LG-100268</span></li>
<li><span class="new">LG-101506</span></li>
<li><span class="new">LG-100754</span></li>
<li><a href="Retinoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Retinoic_acid" title="Retinoic acid">Retinoic acid</a></li>
<li>Retinol (<a href="Vitamin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_A" title="Vitamin A">vitamin A</a>)</li>
<li><span class="new">SR-11237</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">HX-531</span></li>
<li><span class="new">HX-630</span></li>
<li><span class="new">LG-100754</span></li>
<li><span class="new">PA-452</span></li>
<li><span class="new">UVI-3003</span></li>
<li><span class="new">HX-603</span></li>
<li><span class="new">LE135 (RAR beta selective)</span></li>
<li><span class="new">LE-540</span></li>
<li><span class="new">CD3254</span></li>
<li><span class="new">PA-451</span></li>
<li><span class="new">PA-452</span></li>
<li><a href="Rhein_(molecule).htm" tppabs="https://ptable.com/wiki/compounds/A/Rhein_(molecule)" title="Rhein (molecule)">Rhein</a></li>
<li><span class="new">HX-711</span></li>
<li><span class="new">6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid</span></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div>






<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-20" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Isotretinoin&oldid=968616439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Isotretinoin&oldid=968616439'" tppabs="https://en.wikipedia.org/wiki/?title=Isotretinoin&oldid=968616439">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>